OncoTargets and Therapy

Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review

Makita S, Maeshima AM, Maruyama D, Izutsu K, Tobinai K

OncoTargets and Therapy 2018, 11:2287-2293

Published Date: 20 April 2018

Original Research

Oncogene mutational analysis in Chinese gastrointestinal stromal tumor patients

Chen Q, Li R, Zhang Z, Deng Q, Li K, Wang H, Yang X, Wu Y

OncoTargets and Therapy 2018, 11:2279-2286

Published Date: 20 April 2018

Prediction of tumor mutation burden in breast cancer based on the expression of ER, PR, HER-2, and Ki-67

Xu J, Guo X, Jing M, Sun T

OncoTargets and Therapy 2018, 11:2269-2275

Published Date: 19 April 2018

Role of DiGeorge syndrome critical region gene 9, a long noncoding RNA, in gastric cancer

Ni C, Yang P, Guo J, Ye M

OncoTargets and Therapy 2018, 11:2259-2267

Published Date: 19 April 2018

Evidence from an updated meta-analysis of the prognostic impacts of postoperative radiotherapy and chemotherapy in patients with anaplastic thyroid carcinoma

Xia Q, Wang W, Xu J, Chen X, Zhong Z, Sun C

OncoTargets and Therapy 2018, 11:2251-2257

Published Date: 19 April 2018

Original Research

Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine

De Lorenzo C, Paciello R, Riccio G, Rea D, Barbieri A, Coppola C, Maurea N

OncoTargets and Therapy 2018, 11:2241-2250

Published Date: 19 April 2018

microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma

Gao X, Zhu Y, Li JH, Wang X, Zhang X, Yi C, Yang X

OncoTargets and Therapy 2018, 11:2227-2239

Published Date: 19 April 2018

EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients

Lu HY, Qin J, Han N, Lei L, Xie F, Li C

OncoTargets and Therapy 2018, 11:2217-2226

Published Date: 20 April 2018

miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5

Wei X, Yu L, Kong X

OncoTargets and Therapy 2018, 11:2205-2216

Published Date: 18 April 2018

MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial–mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells [Erratum]

Li Y, Huo J, Pan X, Wang C, Ma X

OncoTargets and Therapy 2018, 11:2203-2204

Published Date: 17 April 2018

miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression

Du L, Chen T, Zhao K, Yang D

OncoTargets and Therapy 2018, 11:2195-2202

Published Date: 17 April 2018

The role of Hippo signal pathway in breast cancer metastasis

Wei C, Wang Y, Li X

OncoTargets and Therapy 2018, 11:2185-2193

Published Date: 17 April 2018

Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females

Huang Y, Jian W, Zhao J, Wang G

OncoTargets and Therapy 2018, 11:2177-2184

Published Date: 17 April 2018

Preoperative apolipoprotein B/apolipoprotein A1 ratio: a novel prognostic factor for gastric cancer

Ma MZ, Yuan SQ, Chen Y, Zhou ZW

OncoTargets and Therapy 2018, 11:2169-2176

Published Date: 13 April 2018

Prognostic and clinicopathological value of SIRT3 expression in various cancers: a systematic review and meta-analysis

Zhou Y, Cheng S, Chen S, Zhao Y

OncoTargets and Therapy 2018, 11:2157-2167

Published Date: 13 April 2018

Multiple treatment modalities for brain metastasis in patients with EGFR-mutant non-small-cell lung cancer

Wang HY, Yu X, Fan Y, Jiang Y

OncoTargets and Therapy 2018, 11:2149-2155

Published Date: 13 April 2018

Profile of apalutamide in the treatment of metastatic castration-resistant prostate cancer: evidence to date

Chong JT, Oh WK, Liaw BC

OncoTargets and Therapy 2018, 11:2141-2147

Published Date: 12 April 2018

Albumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patients

Liu C, Wang W, Meng XY, Sun B, Cong Y, Liu JN, Wang Q, Liu GX, Wu SK

OncoTargets and Therapy 2018, 11:2131-2139

Published Date: 12 April 2018

Efficacy of pemetrexed-based regimens in advanced non–small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic review

Han BH, Yang LL, Wang X, Yao LD

OncoTargets and Therapy 2018, 11:2121-2129

Published Date: 12 April 2018

Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma

Huang CK, Huang ZC, Zhao XK, Wang YH, Zhao HQ, Zhong ZH, Wang L

OncoTargets and Therapy 2018, 11:2111-2120

Published Date: 12 April 2018

Small ubiquitin-like modifier 1 modification of pyruvate kinase M2 promotes aerobic glycolysis and cell proliferation in A549 human lung cancer cells

An S, Huang L, Miao P, Shi L, Shen M, Zhao X, Liu J, Huang G

OncoTargets and Therapy 2018, 11:2097-2109

Published Date: 13 April 2018

Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients

Abdel-Razeq H, Saadeh SS, Abu-Nasser M, Abdulelah H, Marie L, Salam M, Al-Haj Ali B, Ibrahim M, Rimawi D

OncoTargets and Therapy 2018, 11:2091-2096

Published Date: 11 April 2018

Investigation of LEP and LEPR polymorphisms with the risk of hepatocellular carcinoma: a case–control study in Eastern Chinese Han population

Zhang S, Jiang J, Chen Z, Wang Y, Tang W, Liu C, Liu L, Chen Y

OncoTargets and Therapy 2018, 11:2083-2089

Published Date: 11 April 2018

Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis

Huang CK, Huang ZC, Bai PM, Luo GC, Zhao XK, Wang XJ

OncoTargets and Therapy 2018, 11:2075-2082

Published Date: 11 April 2018

Role of the NFκB-signaling pathway in cancer

Xia LZ, Tan SM, Zhou YJ, Lin JG, Wang HR, Oyang LD, Tian YT, Liu L, Su M, Wang H, Cao D, Liao QJ

OncoTargets and Therapy 2018, 11:2063-2073

Published Date: 11 April 2018

Combination of SIRT1 and Src overexpression suggests poor prognosis in luminal breast cancer

Tan J, Liu Y, Maimaiti Y, Wang C, Yan Y, Zhou J, Ruan S, Huang T

OncoTargets and Therapy 2018, 11:2051-2061

Published Date: 11 April 2018

IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial-mesenchymal transition in epithelial ovarian cancer

Zhang Y, Wang J, Wu D, Li M, Zhao F, Ren M, Cai Y, Dou J

OncoTargets and Therapy 2018, 11:2037-2050

Published Date: 10 April 2018

β-Catenin-driven adrenocortical carcinoma is characterized with immune exclusion

Liu S, Ding G, Zhou Z, Feng C

OncoTargets and Therapy 2018, 11:2029-2036

Published Date: 9 April 2018

Crocin induces autophagic apoptosis in hepatocellular carcinoma by inhibiting Akt/mTOR activity

Yao C, Liu B, Qian X, Li L, Cao H, Guo Q, Zhou G

OncoTargets and Therapy 2018, 11:2017-2028

Published Date: 9 April 2018

Butein activates p53 in hepatocellular carcinoma cells via blocking MDM2-mediated ubiquitination

Zhou Y, Wang K, Zhou N, Huang T, Zhu J, Li J

OncoTargets and Therapy 2018, 11:2007-2015

Published Date: 6 April 2018

Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombus

Peng C, Gu L, Wang L, Huang Q, Wang B, Guo G, Fan Y, Gao Y, Ma X, Zhang X

OncoTargets and Therapy 2018, 11:1997-2005

Published Date: 6 April 2018

Multiline treatment combining apatinib with toptecan for platinum-resistant recurrent ovarian cancer patients: a report of three cases

Cheng Y, Zhang J, Geng HY, Qin SK, Hua HQ

OncoTargets and Therapy 2018, 11:1989-1995

Published Date: 6 April 2018

Positioning error and expanding margins of planning target volume with kilovoltage cone beam computed tomography for prostate cancer radiotherapy

Wang G, Wang WL, Liu YQ, Dong HM, Hu YX

OncoTargets and Therapy 2018, 11:1981-1988

Published Date: 6 April 2018

Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy

Chen XX, Xia F, Luo JR, Ma JL, Yang ZZ, Zhang L, Feng Y, Shao ZM, Yu XL, Guo XM

OncoTargets and Therapy 2018, 11:1973-1980

Published Date: 5 April 2018

Knockdown of fibrous sheath interacting protein 1 expression reduces bladder urothelial carcinoma cell proliferation and induces apoptosis via inhibition of the PI3K/AKT pathway

Sun M, Chen Z, Tan S, Liu C, Zhao W

OncoTargets and Therapy 2018, 11:1961-1971

Published Date: 5 April 2018

Fabrication of ultrasmall WS2 quantum dots-coated periodic mesoporous organosilica nanoparticles for intracellular drug delivery and synergistic chemo-photothermal therapy

Liao W, Zhang L, Zhong Y, Shen Y, Li C, An N

OncoTargets and Therapy 2018, 11:1949-1960

Published Date: 5 April 2018

Inhibition of NIPBL enhances the chemosensitivity of non-small-cell lung cancer cells via the DNA damage response and autophagy pathway

Zheng L, Zhou H, Guo L, Xu X, Zhang S, Xu W, Mao W

OncoTargets and Therapy 2018, 11:1941-1948

Published Date: 5 April 2018

Downregulation of miR-542-3p promotes cancer metastasis through activating TGF-β/Smad signaling in hepatocellular carcinoma

Zhang T, Liu W, Meng W, Zhao H, Yang Q, Gu SJ, Xiao CC, Jia CC, Fu BS

OncoTargets and Therapy 2018, 11:1929-1939

Published Date: 5 April 2018

PET-CT evaluation of the curative effect of crizotinib on malignant myofibroblastoma with rare mutation of ALK R401: a case report and literature review

Yang L, Wu Y, Tang H, Zhao J, Zhao D, Yang S, Wang Q

OncoTargets and Therapy 2018, 11:1921-1927

Published Date: 5 April 2018

miR-495 inhibits proliferation, migration, and invasion and induces apoptosis via inhibiting PBX3 in melanoma cells

Chen G, Xie Y

OncoTargets and Therapy 2018, 11:1909-1920

Published Date: 5 April 2018

Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort studies

Zhou Y, Cheng S, Fathy AH, Qian H, Zhao Y

OncoTargets and Therapy 2018, 11:1899-1908

Published Date: 5 April 2018

99mTc-labeled sodium phytate and stannous chloride injection accurately detects sentinel lymph node in axillary of early stage breast cancer: a randomized, controlled study

Yang S, Bao W, Bai X, Gao C, Zhang B, Jiang Z

OncoTargets and Therapy 2018, 11:1891-1898

Published Date: 4 April 2018

Long-term survival with transarterial chemoembolization and radioembolization in a patient with cancers of unknown primary

Aktas G, Kus T, Metin T, Kervancioglu S, Elboga U

OncoTargets and Therapy 2018, 11:1885-1889

Published Date: 4 April 2018

Antiangiogenic effects of AA-PMe on HUVECs in vitro and zebrafish in vivo

Jing Y, Wang G, Xiao Q, Zhou Y, Wei Y, Gong Z

OncoTargets and Therapy 2018, 11:1871-1884

Published Date: 4 April 2018

Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis

Zhou L, Du Y, Kong L, Zhang X, Chen Q

OncoTargets and Therapy 2018, 11:1861-1869

Published Date: 4 April 2018

Integrated bioinformatic analysis unveils significant genes and pathways in the pathogenesis of supratentorial primitive neuroectodermal tumor

Wang G, Li L, Liu B, Han X, Wang CH, Wang JW

OncoTargets and Therapy 2018, 11:1849-1859

Published Date: 4 April 2018

D-limonene exhibits antitumor activity by inducing autophagy and apoptosis in lung cancer

Yu X, Lin H, Wang Y, Lv W, Zhang S, Qian Y, Deng X, Feng N, Yu H, Qian B

OncoTargets and Therapy 2018, 11:1833-1847

Published Date: 4 April 2018

Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis

Zhao W, Zang C, Zhang T, Li J, Liu R, Feng F, Lv Q, Zheng L, Tian J, Sun C

OncoTargets and Therapy 2018, 11:1821-1831

Published Date: 3 April 2018

Rare malignant insulinoma with multiple liver metastases derived from ectopic pancreas: 3-year follow-up and literature review

Liu Q, Duan JH, Zheng YM, Luo J, Cai XP, Tan HY

OncoTargets and Therapy 2018, 11:1813-1819

Published Date: 3 April 2018

Association between WWOX and the risk of malignant tumor, especially among Asians: evidence from a meta-analysis

Yuan H, Wu Y, Zhang J, Shi G, Liu D, He Y, Lu Z, Wu P, Jiang K, Miao Y

OncoTargets and Therapy 2018, 11:1801-1811

Published Date: 3 April 2018

Prognostic value of increased integrin-beta 1 expression in solid cancers: a meta-analysis

Sun Q, Zhou C, Ma R, Guo Q, Huang H, Hao J, Liu H, Shi R, Liu B

OncoTargets and Therapy 2018, 11:1787-1799

Published Date: 29 March 2018

Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells

Chiu CM, Huang SY, Chang SF, Liao KF, Chiu SC

OncoTargets and Therapy 2018, 11:1777-1785

Published Date: 29 March 2018

Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen receptor-modified T cells

Mu Q, Jiang M, Zhang Y, Wu F, Li H, Zhang W, Wang F, Liu J, Li L, Wang D, Wang W, Li S, Song H, Tang D

OncoTargets and Therapy 2018, 11:1767-1776

Published Date: 3 April 2018

miR-206 regulates 5-FU resistance by targeting Bcl-2 in colon cancer cells

Meng X, Fu R

OncoTargets and Therapy 2018, 11:1757-1765

Published Date: 29 March 2018

Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers

Dou YL, Lv YL, Zhou XJ, He LF, Liu LH, Li PF, Sun YL, Wang MH, Gao MJ, Wang C

OncoTargets and Therapy 2018, 11:1743-1756

Published Date: 28 March 2018

MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma

Lu Z, Du M, Qian L, Zhang N, Gu J, Ding K, Wu J, Zhu H, He X, Yin L

OncoTargets and Therapy 2018, 11:1733-1741

Published Date: 27 March 2018

miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer

Bao M, Song YJ, Xia JJ, Li PL, Liu Q, Wan ZR

OncoTargets and Therapy 2018, 11:1721-1732

Published Date: 26 March 2018

KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer

Wu Y, Wang A, Zhu B, Huang J, Lu E, Xu H, Xia W, Dong G, Jiang F, Xu L

OncoTargets and Therapy 2018, 11:1707-1720

Published Date: 28 March 2018

Upregulated VEGFA and DLL4 act as potential prognostic genes for clear cell renal cell carcinoma

Wang X, Zhang J, Wang Y, Tu M, Wang Y, Shi G

OncoTargets and Therapy 2018, 11:1697-1706

Published Date: 26 March 2018

Bioinformatic analysis of prognostic value of ZW10 interacting protein in lung cancer

Yuan W, Xie S, Wang M, Pan S, Huang X, Xiong M, Xiao R, Xiong J, Zhang Q, Shao L

OncoTargets and Therapy 2018, 11:1683-1695

Published Date: 23 March 2018

MiR-216b suppresses colorectal cancer proliferation, migration, and invasion by targeting SRPK1

Yao YF, Li QR, Wang H

OncoTargets and Therapy 2018, 11:1671-1681

Published Date: 23 March 2018

The incidence of postoperative radiotherapy-induced acute dermatitis in breast cancer and its influencing factors for Chinese women

Ding J, Guo Y, Li Q, Chen J, Hu P, Liu Q, Cao Y, Wu J

OncoTargets and Therapy 2018, 11:1665-1670

Published Date: 23 March 2018

Biomarker expression in rectal cancer tissue before and after neoadjuvant therapy

Boogerd LS, van der Valk MJM, Boonstra MC, Prevoo HA, Hilling DE, van de Velde CJ, Sier CF, Fariña Sarasqueta A, Vahrmeijer AL

OncoTargets and Therapy 2018, 11:1655-1664

Published Date: 23 March 2018

miR-342-3p suppresses hepatocellular carcinoma proliferation through inhibition of IGF-1R-mediated Warburg effect

Liu W, Kang L, Han J, Wang Y, Shen C, Yan Z, Tai Y, Zhao C

OncoTargets and Therapy 2018, 11:1643-1653

Published Date: 23 March 2018

Effects of isoliquiritigenin on ovarian cancer cells

Li N, Yang L, Deng XN, Sun YN

OncoTargets and Therapy 2018, 11:1633-1642

Published Date: 22 March 2018

Original Research

Open adrenalectomy versus laparoscopic adrenalectomy for adrenocortical carcinoma: a retrospective comparative study on short-term oncologic prognosis

Zheng G, Li H, Deng J, Zhang X, Wu X

OncoTargets and Therapy 2018, 11:1625-1632

Published Date: 21 March 2018

Tooth loss and risk of colorectal cancer: a dose–response meta-analysis of prospective cohort studies

Ma P, Dai S, Jin C, Yao Y, Zou C

OncoTargets and Therapy 2018, 11:1617-1623

Published Date: 21 March 2018

Targeting DTL induces cell cycle arrest and senescence and suppresses cell growth and colony formation through TPX2 inhibition in human hepatocellular carcinoma cells

Chen YC, Chen IS, Huang GJ, Kang CH, Wang KC, Tsao MJ, Pan HW

OncoTargets and Therapy 2018, 11:1601-1616

Published Date: 21 March 2018

Lung squamous cell carcinoma associated with hypoparathyroidism with sensorineural deafness and renal dysplasia syndrome: a case report

Kojima M, Nagano T, Nakata K, Hara S, Katsurada N, Yamamoto M, Tachihara M, Kamiryo H, Kobayashi K, Usui T, Nishimura Y

OncoTargets and Therapy 2018, 11:1595-1599

Published Date: 20 March 2018

Hsp90 inhibitor NMS-E973 exerts the anticancer effect against glioblastoma via induction of PUMA-mediated apoptosis

Sun L, Yang S, Chi G, Jin X

OncoTargets and Therapy 2018, 11:1583-1593

Published Date: 20 March 2018

High expression of COL10A1 is associated with poor prognosis in colorectal cancer

Huang H, Li T, Ye G, Zhao L, Zhang Z, Mo D, Wang Y, Zhang C, Deng H, Li G, Liu H

OncoTargets and Therapy 2018, 11:1571-1581

Published Date: 20 March 2018

Overexpression of HHLA2, a member of the B7 family, is associated with worse survival in human colorectal carcinoma

Zhu Z, Dong W

OncoTargets and Therapy 2018, 11:1563-1570

Published Date: 20 March 2018

Forecast of actin-binding proteins as the oncotarget in osteosarcoma – a review of mechanism, diagnosis and therapy

Fu Y, Yu W, Cai H, Lu A

OncoTargets and Therapy 2018, 11:1553-1561

Published Date: 20 March 2018

Novel long noncoding RNA GACAT3 promotes colorectal cancer cell proliferation, invasion, and migration through miR-149

Zhou W, Wang L, Miao Y, Xing R

OncoTargets and Therapy 2018, 11:1543-1552

Published Date: 19 March 2018

Functional miRNAs in breast cancer drug resistance

Hu WZ, Tan CL, He YJ, Zhang GQ, Xu Y, Tang JH

OncoTargets and Therapy 2018, 11:1529-1541

Published Date: 19 March 2018

Primary mucinous carcinoma of thyroid gland with prominent signet-ring-cell differentiation: a case report and review of the literature

Wang J, Guli QR, Ming XC, Zhou HT, Cui YJ, Jiang YF, Zhang D, Liu Y

OncoTargets and Therapy 2018, 11:1521-1528

Published Date: 16 March 2018

STK39 blockage by RNA interference inhibits the proliferation and induces the apoptosis of renal cell carcinoma

Zhao Q, Zhu YJ, Liu L, Wang H, Jiang S, Hu X, Guo J

OncoTargets and Therapy 2018, 11:1511-1519

Published Date: 16 March 2018

miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma

Wang R, Ma Q, Ji L, Yao Y, Ma M, Wen Q

OncoTargets and Therapy 2018, 11:1501-1509

Published Date: 16 March 2018

Upregulated long non-coding RNAs demonstrate promising efficacy for breast cancer detection: a meta-analysis

Yu G, Zhang W, Zhu L, Xia L

OncoTargets and Therapy 2018, 11:1491-1499

Published Date: 16 March 2018

Midazolam activates caspase, MAPKs and endoplasmic reticulum stress pathways, and inhibits cell cycle and Akt pathway, to induce apoptosis in TM3 mouse Leydig progenitor cells

Kang FC, Wang SC, Chang MM, Pan BS, Wong KL, Cheng KS, So EC, Huang BM

OncoTargets and Therapy 2018, 11:1475-1490

Published Date: 15 March 2018

Identification of differentially expressed genes and signaling pathways in ovarian cancer by integrated bioinformatics analysis

Yang X, Zhu S, Li L, Zhang L, Xian S, Wang Y, Cheng Y

OncoTargets and Therapy 2018, 11:1457-1474

Published Date: 15 March 2018

Modulation of human melanoma cell proliferation and apoptosis by hydatid cyst fluid of Echinococcus granulosus

Gao X, Zhang G, Huang L

OncoTargets and Therapy 2018, 11:1447-1456

Published Date: 15 March 2018

Measurement of serum PODXL concentration for detection of pancreatic cancer

Taniuchi K, Tsuboi M, Sakaguchi M, Saibara T

OncoTargets and Therapy 2018, 11:1433-1445

Published Date: 15 March 2018

Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy

Qian Y, Tao J, Li X, Chen H, Lu Q, Yang J, Pan H, Wang C, Zhou W, Liu X

OncoTargets and Therapy 2018, 11:1423-1432

Published Date: 15 March 2018

Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients

Donizy P, Pagacz K, Marczuk J, Fendler W, Maciejczyk A, Halon A, Matkowski R

OncoTargets and Therapy 2018, 11:1413-1422

Published Date: 14 March 2018

Long non-coding RNA FENDRR inhibits cell proliferation and is associated with good prognosis in breast cancer

Li Y, Zhang W, Liu P, Xu Y, Tang L, Chen W, Guan X

OncoTargets and Therapy 2018, 11:1403-1412

Published Date: 14 March 2018

Fast hemostasis: a win-win strategy for ultrasound and microwave ablation

Guo J, Tian G, Zhao Q, Jiang T

OncoTargets and Therapy 2018, 11:1395-1402

Published Date: 13 March 2018

Rhein inhibits malignant phenotypes of human renal cell carcinoma by impacting on MAPK/NF-κB signaling pathways

Ma YL, Chen F, Shi J

OncoTargets and Therapy 2018, 11:1385-1394

Published Date: 14 March 2018

Reliability of using circulating tumor cells for detecting epidermal growth factor receptor mutation status in advanced non-small-cell lung cancer patients: a meta-analysis and systematic review

Hu F, Mao XW, Zhang YJ, Zheng XX, Gu P, Wang HM, Zhang XY

OncoTargets and Therapy 2018, 11:1373-1384

Published Date: 14 March 2018

Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer

Cymbaluk-Płoska A, Chudecka-Głaz A, Jagodzińska A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Menkiszak J

OncoTargets and Therapy 2018, 11:1363-1372

Published Date: 13 March 2018

Clinicopathological features and prognosis in elderly gastric cancer patients: a retrospective cohort study

Xu G, Feng F, Liu S, Wang F, Zheng G, Wang Q, Cai L, Guo M, Lian X, Zhang H

OncoTargets and Therapy 2018, 11:1353-1362

Published Date: 12 March 2018

IL13Rα2 siRNA inhibited cell proliferation, induced cell apoptosis, and suppressed cell invasion in papillary thyroid carcinoma cells

Gu MJ

OncoTargets and Therapy 2018, 11:1345-1352

Published Date: 9 March 2018

SPP1 promotes ovarian cancer progression via Integrin β1/FAK/Akt signaling pathway

Zeng B, Zhou M, Wu H, Xiong Z

OncoTargets and Therapy 2018, 11:1333-1343

Published Date: 12 March 2018

CREB promotes laryngeal cancer cell migration via MYCT1/NAT10 axis

Zhang ZX, Zhang WN, Sun YY, Li YH, Xu ZM, Fu WN

OncoTargets and Therapy 2018, 11:1323-1331

Published Date: 8 March 2018

Clinicopathological characteristics and prognosis of adult ovarian granulosa cell tumor: a single-institution experience in China

Wang D, Xiang Y, Wu M, Shen K, Yang J, Huang H, Ren T

OncoTargets and Therapy 2018, 11:1315-1322

Published Date: 7 March 2018

Prognostic significance of preoperative IKBKE expression in esophageal squamous cell carcinoma

Yang WJ, Qu Y, Tan BX, Jia YB, Wang NN, Hu P, Wang JB

OncoTargets and Therapy 2018, 11:1305-1314

Published Date: 7 March 2018

The clinicopathological and prognostic value of HSP27 in hepatocellular carcinoma: a systematic review and meta-analysis

Liang CJ, Xu YC, Ge H, Li GM, Wu JX

OncoTargets and Therapy 2018, 11:1293-1303

Published Date: 7 March 2018

Overexpression of c-kit(CD117), relevant with microvessel density, is an independent survival prognostic factor for patients with HBV-related hepatocellular carcinoma

Yan W, Zhu Z, Pan F, Huang A, Dai G

OncoTargets and Therapy 2018, 11:1285-1292

Published Date: 7 March 2018

MicroRNA 302b-3p/302c-3p/302d-3p inhibits epithelial–mesenchymal transition and promotes apoptosis in human endometrial carcinoma cells

Li Y, Huo J, Pan X, Wang C, Ma X

OncoTargets and Therapy 2018, 11:1275-1284

Published Date: 6 March 2018

Vascular endothelial growth factor suppresses dendritic cells function of human prostate cancer

Bai WK, Zhang W, Hu B

OncoTargets and Therapy 2018, 11:1267-1274

Published Date: 6 March 2018

Decreased expression of LKB1 predicts poor prognosis in pancreatic neuroendocrine tumor patients undergoing curative resection

Li D, Zhou Y, Liu Y, Lin Y, Yu M, Lu X, Huang B, Sun Z, Jian Z, Hou B

OncoTargets and Therapy 2018, 11:1259-1265

Published Date: 6 March 2018

Icotinib hydrochloride enhances chemo- and radiosensitivity by inhibiting EGFR signaling and attenuating RAD51 expression and function in Hela S3 cells

Wang X, Gu Y, Liu H, Shi L, Sun X

OncoTargets and Therapy 2018, 11:1245-1258

Published Date: 5 March 2018

Clinical value of Xenopus kinesin-like protein 2 as a prognostic marker in patients with digestive system cancers: a systematic review and meta-analysis

Wang G, Wang Q, Li Z, Liu C, He X

OncoTargets and Therapy 2018, 11:1229-1243

Published Date: 5 March 2018

Original Research

A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey – NOTES study

Yalcin Ş, Yildiz R, Dane F, Karaoğlu A, Öksüzoğlu B, Özyilkan Ö, Sevinç A, Özdemir F, Turna H, Uslu R, Ulay E

OncoTargets and Therapy 2018, 11:1223-1228

Published Date: 5 March 2018

Leukemia-related protein 16 (LRP16) promotes tumor growth and metastasis in pancreatic cancer

Mo Z, Hu MG, Yu F, Shao LJ, Fan KX, Jiao SC

OncoTargets and Therapy 2018, 11:1215-1222

Published Date: 5 March 2018

Clinicopathological significance and prognostic role of p-STAT3 in patients with hepatocellular carcinoma

Liang CJ, Xu Y, Ge H, Li G, Wu J

OncoTargets and Therapy 2018, 11:1203-1214

Published Date: 5 March 2018

Impact of diabetes mellitus on the risk and survival of nasopharyngeal carcinoma: a meta-analysis

Guo G, Fu M, Wei S, Chen R

OncoTargets and Therapy 2018, 11:1193-1201

Published Date: 2 March 2018

Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma

Wang R, Deng D, Shao N, Xu Y, Xue L, Peng Y, Liu Y, Zhi F

OncoTargets and Therapy 2018, 11:1183-1192

Published Date: 2 March 2018

Hepatitis C virus core impacts expression of miR122 and miR204 involved in carcinogenic progression via regulation of TGFBRAP1 and HOTTIP expression

Wang X, Peng J, Wang J, Li M, Wu D, Wu S, Liao J, Dou J

OncoTargets and Therapy 2018, 11:1173-1182

Published Date: 2 March 2018

SIRT1 overexpression protects non-small cell lung cancer cells against osteopontin-induced epithelial-mesenchymal transition by suppressing NF-κB signaling

Li X, Jiang Z, Li XM, Zhang X

OncoTargets and Therapy 2018, 11:1157-1171

Published Date: 2 March 2018

Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study

Sun H, Tang Q, Chen J, Lv X, Tu Y, Yan D

OncoTargets and Therapy 2018, 11:1149-1155

Published Date: 6 March 2018

Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study

Zheng XY, Wang Y, Dong LL, Zhao S, Wang LP, Chen H, Xu Y, Wang GN

OncoTargets and Therapy 2018, 11:1141-1148

Published Date: 1 March 2018

rs11614913 polymorphism in miRNA-196a2 and cancer risk: an updated meta-analysis

Liu Y, He A, Liu B, Zhong Y, Liao X, Yang J, Chen J, Wu J, Mei H

OncoTargets and Therapy 2018, 11:1121-1139

Published Date: 1 March 2018

Response to crizotinib in a non-small-cell lung cancer patient harboring an EML4-ALK fusion with an atypical LTBP1 insertion

Aguado C, Gil MDLL, Yeste Z, Giménez-Capitán A, Teixidó C, Karachaliou N, Viteri S, Rosell R, Molina-Vila MA

OncoTargets and Therapy 2018, 11:1117-1120

Published Date: 1 March 2018

The efficacy and safety of alectinib in the treatment of ALK+ NSCLC: a systematic review and meta-analysis

Fan JS, Xia ZF, Zhang XL, Chen YQ, Qian RL, Liu SH, You DM, Zhang J, Luo P

OncoTargets and Therapy 2018, 11:1105-1115

Published Date: 1 March 2018

TSPAN12 is overexpressed in NSCLC via p53 inhibition and promotes NSCLC cell growth in vitro and in vivo

Hu Z, Hou D, Wang X, You Z, Cao X

OncoTargets and Therapy 2018, 11:1095-1103

Published Date: 1 March 2018

Comparison between multi-slice spiral CT and magnetic resonance imaging in the diagnosis of peritoneal metastasis in primary ovarian carcinoma

Guo HL, He L, Zhu YC, Wu K, Yuan F

OncoTargets and Therapy 2018, 11:1087-1094

Published Date: 28 February 2018

Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer

Jiang DG, Xiao CT, Xian TZ, Wang LT, Mao YH, Zhang JF, Pang J

OncoTargets and Therapy 2018, 11:1077-1086

Published Date: 28 February 2018

Forkhead box K2 inhibits the proliferation, migration, and invasion of human glioma cells and predicts a favorable prognosis

Wang B, Zhang XB, Wang W, Zhu ZZ, Tang F, Wang D, Liu X, Zhuang H, Yan XL

OncoTargets and Therapy 2018, 11:1067-1075

Published Date: 27 February 2018

Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis

Tang L, Li J, Bao M, Xiang J, Chen Y, Wang Y

OncoTargets and Therapy 2018, 11:1055-1066

Published Date: 1 March 2018

CXCR3 is a prognostic marker and a potential target for patients with solid tumors: a meta-analysis

Zhang Y, Xu L, Peng M

OncoTargets and Therapy 2018, 11:1045-1054

Published Date: 27 February 2018

Clinicopathologic characteristics and prognosis of proximal and distal gastric cancer

Yu X, Hu F, Li C, Yao Q, Zhang H, Xue Y

OncoTargets and Therapy 2018, 11:1037-1044

Published Date: 27 February 2018

Reversine, a substituted purine, exerts an inhibitive effect on human renal carcinoma cells via induction of cell apoptosis and polyploidy

Cheng L, Wang H, Guo KC, Wang ZC, Zhang ZY, Shen C, Chen L, Lin J

OncoTargets and Therapy 2018, 11:1025-1035

Published Date: 26 February 2018

Prognostic value of circulating tumor cells detected with the CellSearch System in patients with gastric cancer: evidence from a meta-analysis

Yang C, Zou K, Yuan Z, Guo T, Xiong B

OncoTargets and Therapy 2018, 11:1013-1023

Published Date: 26 February 2018

How many ELNs are optimal for breast cancer patients with more than three PLNs who underwent MRM? A large population-based study

Wang X, Ji C, Chi H, Wang H

OncoTargets and Therapy 2018, 11:1005-1011

Published Date: 26 February 2018

Prognostic significance of Epstein–Barr virus DNA in NK/T-cell lymphoma: a meta-analysis

Fei Q, Tian X, Wu J, Zhu H, Wang Y, Peng F, Zhang W, Yin L, He X

OncoTargets and Therapy 2018, 11:997-1004

Published Date: 26 February 2018

Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway

Yang C, Hou A, Yu C, Dai L, Wang W, Zhang K, Shao H, Ma J, Xu W

OncoTargets and Therapy 2018, 11:983-996

Published Date: 26 February 2018

Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis

Zhou B, Zhan C, Ding Y, Yan S, Zheng S

OncoTargets and Therapy 2018, 11:975-982

Published Date: 23 February 2018

Prognostic significance of mucinous component in gastric adenocarcinoma after radical D2 gastrectomy

Cai L, Li Y, Yang X, Lian X, Guo M, Xiao S, Wang W, Zhang H

OncoTargets and Therapy 2018, 11:967-973

Published Date: 23 February 2018

Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis

Sacdalan DB, Lucero JA, Sacdalan DL

OncoTargets and Therapy 2018, 11:955-965

Published Date: 23 February 2018

Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells

Wang X, Liu Y, Wu R, Guo F, Zhang L, Cui M, Wu X, Zhang Y, Liu W

OncoTargets and Therapy 2018, 11:943-953

Published Date: 22 February 2018

Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines

Sipos E, Dobos N, Rozsa D, Fodor K, Olah G, Szabo Z, Szekvolgyi L, Schally AV, Halmos G

OncoTargets and Therapy 2018, 11:933-941

Published Date: 22 February 2018

The investigation for potential modifier genes in patients with neurofibromatosis type 1 based on next-generation sequencing

Yang F, Xu S, Liu RW, Shi T, Li XF, Li XB, Chen G, Liu HY, Zhou QH, Chen J

OncoTargets and Therapy 2018, 11:919-932

Published Date: 21 February 2018

Low levels of tumor suppressor candidate 3 predict poor prognosis of patients with hepatocellular carcinoma

Sheng XR, Xing SG, Wang RD, Chen K, Jia WD

OncoTargets and Therapy 2018, 11:909-917

Published Date: 21 February 2018

Postoperative hepatic arterial infusion chemotherapy improved survival of pancreatic cancer after radical pancreatectomy: a retrospective study

Wang Y, Xu Y, Zheng Y, Bao Y, Wang P

OncoTargets and Therapy 2018, 11:903-907

Published Date: 21 February 2018

CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker

Shen Z, Yu X, Zheng Y, Lai X, Li J, Hong Y, Zhang H, Chen C, Su Z, Guo R

OncoTargets and Therapy 2018, 11:891-901

Published Date: 20 February 2018

Case Series

Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review

Bi MH, Yang JR, Wang YP, Zhang HR, Gao ZY, Zhou HR, Shi MH

OncoTargets and Therapy 2018, 11:883-890

Published Date: 19 February 2018

Klotho ameliorates sepsis-induced acute kidney injury but is irrelevant to autophagy

Chen X, Tong H, Chen Y, Chen C, Ye J, Mo Q, Zhao G, Hong G, Zheng C, Lu Z

OncoTargets and Therapy 2018, 11:867-881

Published Date: 19 February 2018

Effects of four single nucleotide polymorphisms of EZH2 on cancer risk: a systematic review and meta-analysis

Ling Z, You Z, Hu L, Zhang L, Wang Y, Zhang M, Zhang G, Chen S, Xu B, Chen M

OncoTargets and Therapy 2018, 11:851-865

Published Date: 16 February 2018

Interleukin-33 enhanced the migration and invasiveness of human lung cancer cells

Yang Z, Gao X, Wang J, Xu L, Zheng Y, Xu Y

OncoTargets and Therapy 2018, 11:843-849

Published Date: 16 February 2018

Developments in the management of advanced soft-tissue sarcoma – olaratumab in context

Moroncini G, Maccaroni E, Fiordoliva I, Pellei C, Gabrielli A, Berardi R

OncoTargets and Therapy 2018, 11:833-842

Published Date: 16 February 2018

MiR-1180-5p regulates apoptosis of Wilms’ tumor by targeting p73

Jiang X, Li H

OncoTargets and Therapy 2018, 11:823-831

Published Date: 16 February 2018

Knockdown of KLK11 reverses oxaliplatin resistance by inhibiting proliferation and activating apoptosis via suppressing the PI3K/AKT signal pathway in colorectal cancer cell

Zhang Y, Xu Z, Sun Y, Chi P, Lu X

OncoTargets and Therapy 2018, 11:809-821

Published Date: 16 February 2018

Clinical significance of quantitative HER2 gene amplification as related to its predictive value in breast cancer patients in neoadjuvant setting

Wu Z, Xu S, Zhou L, Yin W, Lin Y, Du Y, Wang Y, Jiang Y, Yin K, Zhang J, Lu J

OncoTargets and Therapy 2018, 11:801-808

Published Date: 15 February 2018

The association between HOTAIR polymorphisms and cancer susceptibility: an updated systemic review and meta-analysis

Min L, Mu X, Tong A, Qian Y, Ling C, Yi T, Zhao X

OncoTargets and Therapy 2018, 11:791-800

Published Date: 14 February 2018

ISL1 is upregulated in breast cancer and promotes cell proliferation, invasion, and angiogenesis

Li L, Sun F, Chen X, Zhang M

OncoTargets and Therapy 2018, 11:781-789

Published Date: 14 February 2018

Antitumor effect of triptolide in T-cell lymphoblastic lymphoma by inhibiting cell viability, invasion, and epithelial–mesenchymal transition via regulating the PI3K/AKT/mTOR pathway

Huang Y, Wu S, Zhang Y, Wang L, Guo Y

OncoTargets and Therapy 2018, 11:769-779

Published Date: 12 February 2018

Raptor mediates the antiproliferation of cardamonin by mTORC1 inhibition in SKOV3 cells

Shi D, Zhu Y, Niu P, Zhou J, Chen H

OncoTargets and Therapy 2018, 11:757-767

Published Date: 9 February 2018

Molecular features of giant-cell carcinoma of the lung: a case report and literature review

Li X, Zhang ZH, Liu JH, Wang D, Wei S, Chen J

OncoTargets and Therapy 2018, 11:751-756

Published Date: 9 February 2018

Expression of Nemo-like kinase in cervical squamous cell carcinoma: a clinicopathological study

Yang W, Gu L, Yang C, Liu T

OncoTargets and Therapy 2018, 11:743-749

Published Date: 8 February 2018

Prognostic significance of epidermal growth factor receptor expression in glioma patients

Li JH, Liang RF, Song C, Xiang YF, Liu YH

OncoTargets and Therapy 2018, 11:731-742

Published Date: 7 February 2018

Efficacy and safety of COX-2 inhibitors for advanced non-small-cell lung cancer with chemotherapy: a meta-analysis

Dai P, Li J, Ma XP, Huang J, Meng JJ, Gong P

OncoTargets and Therapy 2018, 11:721-730

Published Date: 5 February 2018

Use of phosphodiesterase type 5 inhibitors and risk of melanoma: a meta-analysis of observational studies

Han X, Han Y, Zheng Y, Sun Q, Ma T, Dai L, Zhang J, Xu L

OncoTargets and Therapy 2018, 11:711-720

Published Date: 5 February 2018

Association between IL-17A G197A polymorphism and gastric cancer risk: an updated meta-analysis based on 6,624 cases and 7,631 controls

Hu L, Kong F, Pan Y

OncoTargets and Therapy 2018, 11:703-710

Published Date: 5 February 2018

Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins

Ying H, Xu Z, Chen M, Zhou S, Liang X, Cai X

OncoTargets and Therapy 2018, 11:689-702

Published Date: 2 February 2018

PUMA mediates the anti-cancer effect of osimertinib in colon cancer cells [Corrigendum]

Guo L, Huang S, Wang X

OncoTargets and Therapy 2018, 11:687-688

Published Date: 2 February 2018

Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer

Xie L, Li X, Wang Q, Zhou J, Shen J, Luo L, Lu Y, Wang L

OncoTargets and Therapy 2018, 11:677-685

Published Date: 1 February 2018

Associations between ABCG2 gene polymorphisms and gefitinib toxicity in non-small cell lung cancer: a meta-analysis

Tang LN, Zhang CL, He HR, Pan ZY, Fan D, He YL, You HS, Li YJ

OncoTargets and Therapy 2018, 11:665-675

Published Date: 1 February 2018

Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significance

Li J, Ye D, Wang L, Peng Y, Li Q, Deng H, Zhou C

OncoTargets and Therapy 2018, 11:651-663

Published Date: 1 February 2018

LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1

Shang M, Wang X, Zhang Y, Gao Z, Wang T, Liu R

OncoTargets and Therapy 2018, 11:639-649

Published Date: 31 January 2018

The lncRNA PCAT1 is correlated with poor prognosis and promotes cell proliferation, invasion, migration and EMT in osteosarcoma

Zhang X, Zhang Y, Mao Y, Ma X

OncoTargets and Therapy 2018, 11:629-638

Published Date: 31 January 2018

The application of a three-dimensional visualized seed planning and navigation system in 125I seed implantation for pancreatic cancer

Hu YY, Qi EP, Liu FY, Lu YH, Tan SL, Sun Y, Han ZY, Liang P, Yu XL

OncoTargets and Therapy 2018, 11:619-627

Published Date: 31 January 2018

Identification of genomic expression differences between right-sided and left-sided colon cancer based on bioinformatics analysis

Peng Q, Lin K, Chang T, Zou L, Xing P, Shen Y, Zhu Y

OncoTargets and Therapy 2018, 11:609-618

Published Date: 31 January 2018

ALDH1A2 suppresses epithelial ovarian cancer cell proliferation and migration by downregulating STAT3

Wang Y, Shao F, Chen L

OncoTargets and Therapy 2018, 11:599-608

Published Date: 31 January 2018

Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China

Yang YL, Chen K, Zhou YC, Hu ZX, Chen S, Huang YC

OncoTargets and Therapy 2018, 11:587-597

Published Date: 30 January 2018

miR-106b-5p promotes stem cell-like properties of hepatocellular carcinoma cells by targeting PTEN via PI3K/Akt pathway

Shi DM, Bian XY, Qin CD, Wu WZ

OncoTargets and Therapy 2018, 11:571-585

Published Date: 26 January 2018

A non-synonymous polymorphism in NBS1 is associated with progression from chronic hepatitis B virus infection to hepatocellular carcinoma in a Chinese population

Zhen YN, Xiao RX, Chen X, Yuan CJ, Sun YL, Li J

OncoTargets and Therapy 2018, 11:563-569

Published Date: 26 January 2018

Clinical manifestations of pulmonary mucosa-associated lymphoid tissue lymphoma: single-center experience with 18 patients

Zhao S, Zhang L, Gu Z, Zhu C, Fang S, Yang N, Wang F, Guan L, Luo L, Gao C

OncoTargets and Therapy 2018, 11:555-561

Published Date: 24 January 2018

Quantification of heart, pericardium, and left ventricular myocardium movements during the cardiac cycle for thoracic tumor radiotherapy

Tong Y, Yin Y, Lu J, Liu T, Chen J, Cheng P, Gong G

OncoTargets and Therapy 2018, 11:547-554

Published Date: 24 January 2018

Nomogram for predicting survival in patients with pancreatic cancer

Song W, Miao DL, Chen L

OncoTargets and Therapy 2018, 11:539-545

Published Date: 24 January 2018

Review

Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients

Wang LY, Cui JJ, Guo AX, Yin JY

OncoTargets and Therapy 2018, 11:529-538

Published Date: 24 January 2018

The role of bevacizumab in targeted vascular endothelial growth factor therapy for epithelial ovarian cancer: an updated systematic review and meta-analysis

Ruan GY, Ye LX, Liu GF, An J, Sehouli J, Sun PM

OncoTargets and Therapy 2018, 11:521-528

Published Date: 23 January 2018

The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review

Zhang S, Xu XS, Yang JX, Guo JH, Chao TF, Tong YX

OncoTargets and Therapy 2018, 11:509-519

Published Date: 23 January 2018

Prognostic role of neutrophil–lymphocyte ratio in multiple myeloma: a dose–response meta-analysis

Mu S, Ai L, Fan F, Sun C, Hu Y

OncoTargets and Therapy 2018, 11:499-507

Published Date: 23 January 2018

ROS-dependent Bax/Bcl2 and caspase 3 pathway-mediated apoptosis induced by zineb in human keratinocyte cells

Ali D, Tripathi A, Al Ali H, Shahi Y, Mishra KK, Alarifi S, Alkahtane AA, Manohardas S

OncoTargets and Therapy 2018, 11:489-497

Published Date: 23 January 2018

Synovial sarcoma of the maxillary sinus: an extremely rare case with excellent response to chemotherapy

Saito S, Ozawa H, Ikari Y, Nakahara N, Ito F, Sekimizu M, Fukada J, Kameyama K, Ogawa K

OncoTargets and Therapy 2018, 11:483-488

Published Date: 23 January 2018

Homeobox C10 knockdown suppresses cell proliferation and promotes cell apoptosis in osteosarcoma cells through regulating caspase 3

Xie X, Xiao Y, Huang X

OncoTargets and Therapy 2018, 11:473-482

Published Date: 22 January 2018

Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer

Qiu TZ, Chen WS, Li P, Sun J, Gu YH, Chen XF

OncoTargets and Therapy 2018, 11:465-471

Published Date: 22 January 2018

Apatinib-treated advanced medullary thyroid carcinoma: a case report

Chen K, Gao Y, Shi F, Cao G, Bao J

OncoTargets and Therapy 2018, 11:459-463

Published Date: 19 January 2018

Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran

Boostani F, Dolatkhah R, Fakhrjou A, Farassati F, Sanaat Z

OncoTargets and Therapy 2018, 11:449-457

Published Date: 19 January 2018

Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma

Chen JW, Huang CQ, Chen K, Li SM, Zhang X, Cheng J, Cai MY, Xiao Y

OncoTargets and Therapy 2018, 11:441-448

Published Date: 19 January 2018

Long noncoding RNA H19 promotes transforming growth factor-β-induced epithelial–mesenchymal transition by acting as a competing endogenous RNA of miR-370-3p in ovarian cancer cells

Li J, Huang YY, Deng XJ, Luo ML, Wang XF, Hu HY, Liu CD, Zhong M

OncoTargets and Therapy 2018, 11:427-440

Published Date: 18 January 2018

Original Research

Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia

Sevinç A, Özkan M, Özet A, Dane F, Öksüzoğlu B, Işıkdoğan A, Özdemir F, Uncu D, Gümüş M, Evrensel T, Yaren A, Kara O, Tekin SB

OncoTargets and Therapy 2018, 11:419-426

Published Date: 18 January 2018

Neoadjuvant chemoradiotherapy followed by surgery in patients with unresectable locally advanced colon cancer: a prospective observational study

Chang H, Yu X, Xiao W, Wang QX, Zhou WH, Zeng ZF, Ding PR, Li L, Gao YH

OncoTargets and Therapy 2018, 11:409-418

Published Date: 17 January 2018

Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway

Daya M, Loilome W, Techasen A, Thanee M, Sa-Ngiamwibool P, Titapun A, Yongvanit P, Namwat N

OncoTargets and Therapy 2018, 11:395-408

Published Date: 18 January 2018

Prognostic role of HSF1 overexpression in solid tumors: a pooled analysis of 3,159 patients

Wan T, Shao J, Hu B, Liu G, Luo P, Zhou Y

OncoTargets and Therapy 2018, 11:383-393

Published Date: 17 January 2018

Comparison of FOLFOX and DOF regimens as first-line treatment in East Asian patients with advanced gastric cancer

Liu M, Hu G, Wang Y, Guo J, Liu L, Han X, Wang Z

OncoTargets and Therapy 2018, 11:375-381

Published Date: 17 January 2018

Combination of betulinic acid with diazen-1-ium-1,2-diolate nitric oxide moiety donating a novel anticancer candidate

Zhang L, Hou S, Li B, Pan J, Jiang L, Zhou G, Gu H, Zhao C, Lu H, Ma F

OncoTargets and Therapy 2018, 11:361-373

Published Date: 15 January 2018

Prognostic role of HSPs in human gastrointestinal cancer: a systematic review and meta-analysis

Ge H, Yan Y, Guo L, Tian F, Wu D

OncoTargets and Therapy 2018, 11:351-359

Published Date: 15 January 2018

Safety and efficacy of transarterial chemoembolization with degradable starch microspheres (DSM-TACE) in the treatment of secondary liver malignancies

Schicho A, Pereira PL, Michalik K, Beyer LP, Stroszczynski C, Wiggermann P

OncoTargets and Therapy 2018, 11:345-350

Published Date: 12 January 2018

The clinical characteristics and prognostic analysis of Chinese advanced NSCLC patients based on circulating tumor DNA sequencing

Rao C, Nie L, Miao X, Xu Y, Li B, Zhang T

OncoTargets and Therapy 2018, 11:337-344

Published Date: 12 January 2018

High-frequency deregulated expression of Wnt signaling pathway members in breast carcinomas

Khan Z, Arafah M, Shaik JP, Mahale A, Alanazi MS

OncoTargets and Therapy 2018, 11:323-335

Published Date: 11 January 2018

The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/β-Catenin pathway

Jia L, Tian Y, Chen Y, Zhang G

OncoTargets and Therapy 2018, 11:313-321

Published Date: 11 January 2018

A novel tumor suppressor gene NCOA5 is correlated with progression in papillary thyroid carcinoma

Zheng Z, Wang Q, Zhang W, Zhang X, Huang D

OncoTargets and Therapy 2018, 11:307-311

Published Date: 11 January 2018

Comparative study of clinical efficacy using three-dimensional and two-dimensional laparoscopies in the treatment of distal gastric cancer

Liu JG, Zhou HT, Qin HQ, Ru HM, Huang JH, Liang SY, Mo XW, Tang WZ

OncoTargets and Therapy 2018, 11:301-306

Published Date: 11 January 2018

Exosome-mediated delivery of MALAT1 induces cell proliferation in breast cancer

Zhang P, Zhou H, Lu K, Lu Y, Wang Y, Feng T

OncoTargets and Therapy 2018, 11:291-299

Published Date: 9 January 2018

Over-expression of ARHGAP18 suppressed cell proliferation, migration, invasion, and tumor growth in gastric cancer by restraining over-activation of MAPK signaling pathways

Li Y, Ji S, Fu L, Jiang T, Wu D, Meng F

OncoTargets and Therapy 2018, 11:279-290

Published Date: 9 January 2018

Experimental study of inhibitory effects of diallyl trisulfide on the growth of human osteosarcoma Saos-2 cells by downregulating expression of glucose-regulated protein 78

Zhang Y, Xie WP, Zhang YK, Chen YQ, Wang DL, Li G, Guan DH

OncoTargets and Therapy 2018, 11:271-277

Published Date: 9 January 2018

A support vector machine and a random forest classifier indicates a 15-miRNA set related to osteosarcoma recurrence

He Y, Ma J, Wang A, Wang W, Luo S, Liu Y, Ye X

OncoTargets and Therapy 2018, 11:253-269

Published Date: 5 January 2018

miR-99a-5p acts as tumor suppressor via targeting to mTOR and enhances RAD001-induced apoptosis in human urinary bladder urothelial carcinoma cells

Tsai TF, Lin JF, Chou KY, Lin YC, Chen HE, Hwang TIS

OncoTargets and Therapy 2018, 11:239-252

Published Date: 4 January 2018

Transcriptional profiling of NCI/ADR-RES cells unveils a complex network of signaling pathways and molecular mechanisms of drug resistance

Vert A, Castro J, Ribó M, Vilanova M, Benito A

OncoTargets and Therapy 2018, 11:221-237

Published Date: 4 January 2018

RACK1 induces chemotherapy resistance in esophageal carcinoma by upregulating the PI3K/AKT pathway and Bcl-2 expression

Liu B, Wang C, Chen P, Cheng B, Cheng Y

OncoTargets and Therapy 2018, 11:211-220

Published Date: 4 January 2018

KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth

Wang Y, Zang J, Zhang D, Sun Z, Qiu B, Wang X

OncoTargets and Therapy 2018, 11:201-209

Published Date: 8 January 2018

Autophagy suppresses proliferation of HepG2 cells via inhibiting glypican-3/wnt/β-catenin signaling

Hu P, Cheng B, He Y, Wei Z, Wu D, Meng Z

OncoTargets and Therapy 2018, 11:193-200

Published Date: 4 January 2018

The effects of naloxone on human breast cancer progression: in vitro and in vivo studies on MDA.MB231 cells

Bimonte S, Barbieri A, Cascella M, Rea D, Palma G, Del Vecchio V, Forte CA, Del Prato F, Arra C, Cuomo A

OncoTargets and Therapy 2018, 11:185-191

Published Date: 3 January 2018

Cancer stem cells, the ultimate targets in cancer therapy

Shabbir A, Esfandyari T, Farassati F

OncoTargets and Therapy 2018, 11:183-184

Published Date: 3 January 2018

Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy

Weisberg E, Sattler M, Manley PW, Griffin JD

OncoTargets and Therapy 2018, 11:175-182

Published Date: 29 December 2017

Identification of key pathways and genes in TP53 mutation acute myeloid leukemia: evidence from bioinformatics analysis

Huang R, Liao X, Li Q

OncoTargets and Therapy 2018, 11:163-173

Published Date: 28 December 2017

A patient with classic biphasic pulmonary blastoma harboring CD74–ROS1 fusion responds to crizotinib

Meng Z, Chen P, Zang F, Liu Y, Xu X, Su Y, Chen J, Lin L, Zhang L, Zhang T

OncoTargets and Therapy 2018, 11:157-161

Published Date: 28 December 2017

Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy

Castelli G, Pelosi E, Testa U

OncoTargets and Therapy 2018, 11:131-155

Published Date: 28 December 2017

Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC

Tang XM, Chen H, Li Q, Song YL, Zhang SP, Xu XS, Xu YW, Chen SL

OncoTargets and Therapy 2018, 11:123-129

Published Date: 28 December 2017

A retrospective examination of the US Food and Drug Administration’s clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring

Fleisher B, Ait-Oudhia S

OncoTargets and Therapy 2018, 11:113-121

Published Date: 27 December 2017

The putative tumor suppressor, miR-199a, regulated by Snail, modulates clear cell renal cell carcinoma aggressiveness by repressing ROCK1

Zhang X, Li P, Ding Z, Wang H, Wang J, Han L, Ding S

OncoTargets and Therapy 2018, 11:103-112

Published Date: 27 December 2017

The RNASEL −1385G/A polymorphism is associated with risk of prostate cancer in Africans

Liu X, Zheng D, Lu G, Yang B

OncoTargets and Therapy 2018, 11:97-102

Published Date: 22 December 2017

Prognosis of patients with primary malignant main stem bronchial tumors: 7,418 cases based on the SEER database

Ma K, Sun F, Yang X, Wang S, Wang L, Jin Y, Shi Y, Jiang W, Zhan C, Wang Q

OncoTargets and Therapy 2018, 11:83-95

Published Date: 22 December 2017

Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA

DiBonaventura MD, Wong W, Shah-Manek B, Schulz M

OncoTargets and Therapy 2018, 11:75-82

Published Date: 22 December 2017

miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition

Ren H, Qi Y, Yin X, Gao J

OncoTargets and Therapy 2018, 11:67-74

Published Date: 22 December 2017

Pretreatment platelet count as a prognostic factor in patients with pancreatic cancer: a systematic review and meta-analysis

Chen S, Na N, Jian Z

OncoTargets and Therapy 2018, 11:59-65

Published Date: 21 December 2017

Clinicopathological and prognostic significance of OCT4 in patients with hepatocellular carcinoma: a meta-analysis

Liang CJ, Xu YC, Ge H, Li GM, Wu JX

OncoTargets and Therapy 2018, 11:47-57

Published Date: 21 December 2017

Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer

Wang Y, Jin Y, Bhandari A, Yao Z, Yang F, Pan Y, Zheng Z, Lv S, Wang O

OncoTargets and Therapy 2018, 11:37-46

Published Date: 21 December 2017

Four-miRNA signature as a prognostic tool for lung adenocarcinoma

Lin Y, Lv Y, Liang R, Yuan C, Zhang J, He D, Zheng X, Zhang J

OncoTargets and Therapy 2018, 11:29-36

Published Date: 21 December 2017

Quercetin suppresses DNA double-strand break repair and enhances the radiosensitivity of human ovarian cancer cells via p53-dependent endoplasmic reticulum stress pathway

Gong C, Yang Z, Zhang L, Wang Y, Gong W, Liu Y

OncoTargets and Therapy 2018, 11:17-27

Published Date: 21 December 2017

Identification of epigenetically altered genes and potential gene targets in melanoma using bioinformatic methods

Duan HH, Jiang K, Wei DK, Zhang LJ, Cheng DL, Lv M, Xu YB, He AM

OncoTargets and Therapy 2018, 11:9-15

Published Date: 20 December 2017

ERCC1 rs3212986 A/C polymorphism is not associated with chemotherapy treatment outcomes in gastric cancer patients: evidence from 11 publications in Chinese populations

Tang WW, Wang H, Wang YM, Wang XW

OncoTargets and Therapy 2018, 11:1-8

Published Date: 20 December 2017

ALK-positive anaplastic large cell lymphoma with soft tissue involvement in a young woman [Retraction]

Gao K, Li H, Huang C, Li H, Fang J, Tian C

OncoTargets and Therapy 2017, 10:5945-5946

Published Date: 18 December 2017

Myometrial invasion and overall staging of endometrial carcinoma: assessment using fusion of T2-weighted magnetic resonance imaging and diffusion-weighted magnetic resonance imaging

Guo Y, Wang P, Wang P, Gao W, Li F, Yang X, Ni H, Shen W, Guo Z

OncoTargets and Therapy 2017, 10:5937-5943

Published Date: 15 December 2017

SUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma [Retraction]

Huang W, Huang H, Wang L, Hu J, Song W

OncoTargets and Therapy 2017, 10:5935-5936

Published Date: 18 December 2017

Nuclear expression of XBP1s is correlated with breast cancer survival: a retrospective analysis based on tissue microarray

Wang M, Ruan S, Ming J, Dong F

OncoTargets and Therapy 2017, 10:5927-5934

Published Date: 13 December 2017

Seven-microRNA panel for lung adenocarcinoma early diagnosis in patients presenting with ground-glass nodules

He Y, Yang Y, Kuang P, Ren S, Rozeboom L, Rivard CJ, Li X, Zhou C, Hirsch FR

OncoTargets and Therapy 2017, 10:5915-5926

Published Date: 13 December 2017

High expression of CIP2A protein is associated with tumor aggressiveness in stage I–III NSCLC and correlates with poor prognosis

Cha GQ, Xu JY, Xu XY, Li B, Lu S, Nanding AB, Hu SL, Liu SL

OncoTargets and Therapy 2017, 10:5907-5914

Published Date: 12 December 2017

miR-199a modulates cisplatin resistance in ovarian cancer by targeting Hif1α

Feng X, Liu N, Deng S, Zhang DD, Wang KX, Lu MS

OncoTargets and Therapy 2017, 10:5899-5906

Published Date: 12 December 2017

Integrative analysis of lncRNAs and miRNAs with coding RNAs associated with ceRNA crosstalk network in triple negative breast cancer

Yuan NJ, Zhang G, Bie FJ, Ma M, Ma Y, Jiang X, Wang Y, Hao X

OncoTargets and Therapy 2017, 10:5883-5897

Published Date: 12 December 2017

Targeting of GIT1 by miR-149* in breast cancer suppresses cell proliferation and metastasis in vitro and tumor growth in vivo

Dong Y, Chang C, Liu J, Qiang J

OncoTargets and Therapy 2017, 10:5873-5882

Published Date: 11 December 2017

Overexpression of UHRF2 in intrahepatic cholangiocarcinoma and its clinical significance

Peng R, Huang X, Zhang C, Yang X, Xu Y, Bai D

OncoTargets and Therapy 2017, 10:5863-5872

Published Date: 11 December 2017

Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells

Cheng X, Liu Z, Shang L, Cai H, Zhang Y, Cai Y, Xu X, Hao J, Wang M

OncoTargets and Therapy 2017, 10:5855-5862

Published Date: 11 December 2017

Long noncoding RNA NEAT1 promotes nasopharyngeal carcinoma progression through regulation of miR-124/NF-κB pathway

Cheng N, Guo Y

OncoTargets and Therapy 2017, 10:5843-5853

Published Date: 11 December 2017

Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma

Huang JF, Zou QZ, Qian DQ, Zhou LY, Yang B, Chu JJ, Pang QF, Wang KW, Zhang FZ

OncoTargets and Therapy 2017, 10:5835-5841

Published Date: 8 December 2017

The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer

Wu Y, Gong L, Xu J, Mou Y, Xu X, Qian Z

OncoTargets and Therapy 2017, 10:5827-5834

Published Date: 8 December 2017

Chemotherapy induces ovarian cancer cell repopulation through the caspase 3-mediated arachidonic acid metabolic pathway

Cui LZ, Zhao YW, Pan Y, Zheng X, Shao D, Jia Y, He K, Li K, Chen L

OncoTargets and Therapy 2017, 10:5817-5826

Published Date: 8 December 2017

Prognostic role of CD82/KAI1 in multiple human malignant neoplasms: a meta-analysis of 31 studies

Zhu J, Miao C, Liu S, Tian Y, Zhang C, Liang C, Xu A, Cao Q, Wang Z

OncoTargets and Therapy 2017, 10:5805-5816

Published Date: 6 December 2017

The combination astemizole–gefitinib as a potential therapy for human lung cancer

Chávez-López MDG, Zúñiga-García V, Hernández-Gallegos E, Vera E, Chasiquiza-Anchatuña CA, Viteri-Yánez M, Sanchez-Ramos J, Garrido E, Camacho J

OncoTargets and Therapy 2017, 10:5795-5803

Published Date: 6 December 2017

CircRNA_100782 regulates pancreatic carcinoma proliferation through the IL6-STAT3 pathway

Chen G, Shi Y, Zhang Y, Sun J

OncoTargets and Therapy 2017, 10:5783-5794

Published Date: 5 December 2017

Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy

Zhong W, Zhang L, Ma J, Shao S, Lin R, Li X, Xiong G, Fang D, Zhou L

OncoTargets and Therapy 2017, 10:5775-5782

Published Date: 5 December 2017

Hopea odorata extract inhibits hepatocellular carcinoma via induction of caspase-dependent apoptosis

Nguyen ST, Huynh KL, Nguyen HL, Nguyen Thi Thanh M, Nguyen Trung N, Nguyen Xuan H, Ngoc KP, Truong Dinh K, Pham PV

OncoTargets and Therapy 2017, 10:5765-5774

Published Date: 4 December 2017

Differential radiation response between normal astrocytes and glioma cells revealed by comparative transcriptome analysis

Gong L, Gu JC, Ge JW, Wu X, Zhang C, Yang C, Weng WJ, Gao GY, Feng JF, Mao Q

OncoTargets and Therapy 2017, 10:5755-5764

Published Date: 4 December 2017

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma

Qi X, Jia B, Zhao X, Yu D

OncoTargets and Therapy 2017, 10:5745-5754

Published Date: 1 December 2017

Cisplatin versus carboplatin in combination with paclitaxel as neoadjuvant regimen for triple negative breast cancer

Huang L, Liu Q, Chen S, Shao ZM

OncoTargets and Therapy 2017, 10:5739-5744

Published Date: 1 December 2017

Predictive value of interim PET/CT visual interpretation in the prognosis of patients with aggressive non-Hodgkin’s lymphoma

Liao CC, Qin YY, Tan XH, Hu JJ, Tang Q, Rong Y, Cen H, Li LQ

OncoTargets and Therapy 2017, 10:5727-5738

Published Date: 30 November 2017

Low expression of DAB2IP predicts an unfavorable prognosis in human bladder carcinoma

Zheng L, Chen K, Zhu L, Su D, Cheng G

OncoTargets and Therapy 2017, 10:5719-5726

Published Date: 29 November 2017

Expression patterns of microRNA-329 and its clinical performance in diagnosis and prognosis of breast cancer

Li P, Dong J, Zhou X, Sun W, Huang H, Chen T, Ye B, Zheng Z, Lu M

OncoTargets and Therapy 2017, 10:5711-5718

Published Date: 28 November 2017

Antitumor effects of pristimerin on human osteosarcoma cells in vitro and in vivo

Mori Y, Shirai T, Terauchi R, Tsuchida S, Mizoshiri N, Hayashi D, Arai Y, Kishida T, Mazda O, Kubo T

OncoTargets and Therapy 2017, 10:5703-5710

Published Date: 28 November 2017

Diagnostic significance of circulating long noncoding RNA PCAT6 in patients with non-small cell lung cancer

Wan L, Zhang L, Fan K, Wang JJ

OncoTargets and Therapy 2017, 10:5695-5702

Published Date: 28 November 2017

PBX3 is associated with proliferation and poor prognosis in patients with cervical cancer

Li H, Sun G, Liu C, Wang J, Jing R, Wang J, Zhao X, Xu X, Yang Y

OncoTargets and Therapy 2017, 10:5685-5694

Published Date: 27 November 2017

The combination of systemic therapy and locoregional radiotherapy prolongs survival in newly diagnosed metastatic nasopharyngeal carcinoma patients

Yin Z, Zhang X, Wang Y, Wang P, Yuan Z

OncoTargets and Therapy 2017, 10:5677-5683

Published Date: 27 November 2017

MicroRNA-211 promotes non-small-cell lung cancer proliferation and invasion by targeting MxA

Kang M, Shi J, Peng N, He S

OncoTargets and Therapy 2017, 10:5667-5675

Published Date: 28 November 2017

The combination therapy of salinomycin and gefitinib using poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cells

Zhang Y, Zhang Q, Sun J, Liu H, Li Q

OncoTargets and Therapy 2017, 10:5653-5666

Published Date: 27 November 2017

18F-fluorodeoxyglucose uptake predicts MET expression in lung adenocarcinoma

An S, Zhou X, Liu J, Huang G

OncoTargets and Therapy 2017, 10:5643-5651

Published Date: 27 November 2017

Microtubule-targeting agents can sensitize cancer cells to ionizing radiation by an interphase-based mechanism

Markowitz D, Ha G, Ruggieri R, Symons M

OncoTargets and Therapy 2017, 10:5633-5642

Published Date: 24 November 2017

Original Research

Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer

He L, Zhang S, Zhang X, Liu R, Guan H, Zhang H

OncoTargets and Therapy 2017, 10:5621-5631

Published Date: 24 November 2017

RKIP reduction enhances radioresistance by activating the Shh signaling pathway in non-small-cell lung cancer

Xie SY, Li G, Han C, Yu YY, Li N

OncoTargets and Therapy 2017, 10:5605-5619

Published Date: 23 November 2017

Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma

Feng SD, Mao ZM, Liu CY, Nie YS, Sun B, Guo MG, Su CQ

OncoTargets and Therapy 2017, 10:5591-5604

Published Date: 23 November 2017

Clinical application of carbon nanoparticles in curative resection for colorectal carcinoma

Wang LY, Li JH, Zhou X, Zheng QC, Cheng X

OncoTargets and Therapy 2017, 10:5585-5589

Published Date: 22 November 2017

Lymphocyte-to-monocyte ratio before chemoradiotherapy represents a prognostic predictor for locally advanced rectal cancer

Deng YX, Lin JZ, Peng JH, Zhao YJ, Sui QQ, Wu XJ, Lu ZH, Gao YH, Zeng ZF, Pan ZZ

OncoTargets and Therapy 2017, 10:5575-5583

Published Date: 22 November 2017

The clinical significance of CXCL5 in non-small cell lung cancer

Wu K, Yu S, Liu Q, Bai X, Zheng X, Wu K

OncoTargets and Therapy 2017, 10:5561-5573

Published Date: 21 November 2017

Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis

Zhao F, Ge YZ, Zhou LH, Xu LW, Xu Z, Ping WW, Wang M, Zhou CC, Wu R, Jia RP

OncoTargets and Therapy 2017, 10:5551-5559

Published Date: 22 November 2017

Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ

Cui J, Chen S, Bo Q, Wang S, Zhang N, Yu M, Wang W, Han J, Zhu Y, Shi B

OncoTargets and Therapy 2017, 10:5541-5550

Published Date: 21 November 2017

Prognostic and clinicopathological significance of ubiquitin-specific protease 22 overexpression in cancers: evidence from a meta-analysis

Ao N, Wang L, Liu Y

OncoTargets and Therapy 2017, 10:5533-5540

Published Date: 21 November 2017

The relationship between IGF2BP2 and PPARG polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population

Qiu H, Wang Y, Kang M, Ding H, Liu C, Tang W, Xiao Z, Chen Y

OncoTargets and Therapy 2017, 10:5525-5532

Published Date: 21 November 2017

The crossroads of breast cancer progression: insights into the modulation of major signaling pathways

Velloso FJ, Bianco AFR, Farias JO, Torres NEC, Ferruzo PY, Anschau V, Jesus-Ferreira HC, Chang TH, Sogayar MC, Zerbini LF, Correa RG

OncoTargets and Therapy 2017, 10:5491-5524

Published Date: 20 November 2017

Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma [Corrigendum]

Zhang MC, Yan ZL, Wang JJ, Yao XQ

OncoTargets and Therapy 2017, 10:5489-5490

Published Date: 16 November 2017

Original Research

Cytomembranic PD-L1 expression in locoregionally advanced nasopharyngeal carcinoma

Zheng L, Cao C, Cheng G, Hu Q, Chen X

OncoTargets and Therapy 2017, 10:5483-5487

Published Date: 16 November 2017

Curcumin potentiates the potent antitumor activity of ACNU against glioblastoma by suppressing the PI3K/AKT and NF-κB/COX-2 signaling pathways

Zhao J, Zhu J, Lv X, Xing J, Liu S, Chen C, Xu Y

OncoTargets and Therapy 2017, 10:5471-5482

Published Date: 15 November 2017

Identification of COX5B as a novel biomarker in high-grade glioma patients

Hu T, Xi J

OncoTargets and Therapy 2017, 10:5463-5470

Published Date: 15 November 2017

Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature

Zhang L, Zhang C, Yang Z, He M, Zhang L, Ezzat S, Liang X

OncoTargets and Therapy 2017, 10:5459-5462

Published Date: 14 November 2017

Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma

Li Z, Li Y, Yan S, Fu J, Zhou Q, Huang X, Shen L

OncoTargets and Therapy 2017, 10:5445-5458

Published Date: 14 November 2017

Clinical significance of CMTM4 expression in hepatocellular carcinoma

Bei CH, Zhang Y, Wei RM, Zhu XN, Wang ZG, Zeng W, Chen QY, Tan SK

OncoTargets and Therapy 2017, 10:5439-5443

Published Date: 14 November 2017

The effect of CYP2D6 *10 polymorphism on adjuvant tamoxifen in Asian breast cancer patients: a meta-analysis

Lu J, Li H, Guo P, Shen R, Luo Y, Ge Q, Shi WF, Li Y, Zhu W

OncoTargets and Therapy 2017, 10:5429-5437

Published Date: 13 November 2017

Effective treatment of low-dose decitabine in myelodysplastic syndrome/myeloproliferative neoplasms

Ye X, Chen D, Zheng Y, Zhu X, Fu J, Huang J

OncoTargets and Therapy 2017, 10:5425-5428

Published Date: 13 November 2017

Expression and significance of B7-H3 and Tie-2 in the tumor vasculature of clear cell renal carcinoma

Zhang X, Ji J, Zhang G, Fang C, Jiang F, Ma S, Hou J

OncoTargets and Therapy 2017, 10:5417-5424

Published Date: 13 November 2017

In vitro study on anti-cancer properties of genistein in tongue cancer

Ardito F, Pellegrino MR, Perrone D, Troiano G, Cocco A, Lo Muzio L

OncoTargets and Therapy 2017, 10:5405-5415

Published Date: 13 November 2017

Therapeutic efficacy and safety of combined BRAF and MEK inhibition in patients with malignant melanoma: a meta-analysis

Chen P, Chen FC, Zhou BH

OncoTargets and Therapy 2017, 10:5391-5403

Published Date: 13 November 2017

LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194

An J, Lv W, Zhang Y

OncoTargets and Therapy 2017, 10:5377-5390

Published Date: 10 November 2017

The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis

Chen X, Cheng J, Huang A, Zhang X, Wang J, Fan J, Zhou J, Yang X

OncoTargets and Therapy 2017, 10:5363-5375

Published Date: 10 November 2017

LncRNA expression and implication in osteosarcoma: a systematic review and meta-analysis

Wang Y, Huang YL, Xiang P, Tian W

OncoTargets and Therapy 2017, 10:5355-5361

Published Date: 9 November 2017

Review

Amatuximab and novel agents targeting mesothelin for solid tumors

Baldo P, Cecco S

OncoTargets and Therapy 2017, 10:5337-5353

Published Date: 8 November 2017

Interleukin-6 upregulates SOX18 expression in osteosarcoma

Wu Z, Yang W, Liu J, Zhang F

OncoTargets and Therapy 2017, 10:5329-5336

Published Date: 8 November 2017

FGF2 promotes metastasis of uveal melanoma cells via store-operated calcium entry

Wang Y, Bao X, Zhang Z, Sun Y, Zhou X

OncoTargets and Therapy 2017, 10:5317-5328

Published Date: 8 November 2017

Primary site surgery for metastatic adrenocortical carcinoma improves survival outcomes: an analysis of a population-based database

Wang S, Gao W, Chen S, Bai L, Luo L, Zheng X, Luo Y

OncoTargets and Therapy 2017, 10:5311-5315

Published Date: 8 November 2017

UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis

Wang B, Shen J, Wang J

OncoTargets and Therapy 2017, 10:5303-5309

Published Date: 6 November 2017

The associations between common SNPs of EFEMP1 gene and glioma risk in Chinese population

Hu J, Dong D, Lu DD

OncoTargets and Therapy 2017, 10:5297-5302

Published Date: 6 November 2017

Analysis of the factors affecting the safety of robotic stereotactic body radiation therapy for hepatocellular carcinoma patients

Liu XJ, Song YC, Liang P, Su TS, Zhang HJ, Zhao XZ, Yuan ZY, Wang P

OncoTargets and Therapy 2017, 10:5289-5295

Published Date: 6 November 2017

PUMA mediates the anti-cancer effect of osimertinib in colon cancer cells

Guo L, Huang S, Wang X

OncoTargets and Therapy 2017, 10:5281-5288

Published Date: 3 November 2017

S100A16, a promising candidate as a prognostic marker for platinum-based adjuvant chemotherapy in resected lung adenocarcinoma

Katono K, Sato Y, Kobayashi M, Nagashio R, Ryuge S, Igawa S, Ichinoe M, Murakumo Y, Saegusa M, Masuda N

OncoTargets and Therapy 2017, 10:5273-5279

Published Date: 2 November 2017

Association of GEMIN4 gene polymorphism and the risk of cancer: a meta-analysis

Wu N, Zhang X, Tian J, Yu S, Qiao Y

OncoTargets and Therapy 2017, 10:5263-5271

Published Date: 2 November 2017

Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma

Li YJ, Yao K, Lu MX, Zhang WB, Xiao C, Tu CQ

OncoTargets and Therapy 2017, 10:5255-5261

Published Date: 2 November 2017

Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia

Huang R, Liao XW, Li Q

OncoTargets and Therapy 2017, 10:5243-5254

Published Date: 2 November 2017

Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report

Ma FC, Yu Q, Zeng ZM, He RQ, Mo CH, Zhong JC, Ma J, Feng ZB, Chen G, Hu XH

OncoTargets and Therapy 2017, 10:5237-5242

Published Date: 1 November 2017

MicroRNAs as a novel class of diagnostic biomarkers for the detection of osteosarcoma: a meta-analysis

Liu H, Li P, Chen L, Jian C, Li ZH, Yu AX

OncoTargets and Therapy 2017, 10:5229-5236

Published Date: 1 November 2017

Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis

Gao XL, Zhang M, Tang YL, Liang XH

OncoTargets and Therapy 2017, 10:5219-5228

Published Date: 27 October 2017

Matrine suppresses the migration and invasion of NSCLC cells by inhibiting PAX2-induced epithelial-mesenchymal transition

Yang J, He D, Peng Y, Zhong HZ, Deng YH, Yu Z, Guan C, Zuo Y, Xu Z

OncoTargets and Therapy 2017, 10:5209-5217

Published Date: 27 October 2017

Current status of poly(ADP-ribose) polymerase inhibitors and future directions

Ohmoto A, Yachida S

OncoTargets and Therapy 2017, 10:5195-5208

Published Date: 26 October 2017

The expression profile and clinical significance of circRNA0003906 in colorectal cancer

Zhuo F, Lin HS, Chen ZX, Huang ZJ, Hu JP

OncoTargets and Therapy 2017, 10:5187-5193

Published Date: 25 October 2017

Frequency and clinical relevance of EGFR mutations and EML4–ALK translocations in octogenarians with non-small cell lung cancer

Tufman A, Kahnert K, Duell T, Kauffmann-Guerrero D, Milger K, Schneider C, Stump J, Syunyaeva Z, Huber RM, Reu S

OncoTargets and Therapy 2017, 10:5179-5186

Published Date: 25 October 2017

Impact of hypertrophic pulmonary osteoarthropathy on patients with lung cancer

Fang YH, Hsu CC, Hsieh MJ, Hung MS, Tsai YH, Lin YC

OncoTargets and Therapy 2017, 10:5173-5177

Published Date: 25 October 2017

Low-grade central osteosarcoma in proximal humerus: a rare entity

Tang F, Min L, Zhou Y, Luo Y, Tu CQ

OncoTargets and Therapy 2017, 10:5165-5172

Published Date: 24 October 2017

Overexpression of MPC1 inhibits the proliferation, migration, invasion, and stem cell-like properties of gastric cancer cells

Zhou X, Xiong ZJ, Xiao SM, Zhou J, Ding Z, Tang LC, Chen XD, Xu R, Zhao P

OncoTargets and Therapy 2017, 10:5151-5163

Published Date: 24 October 2017

LncRNA MEG3 enhances cisplatin sensitivity in non-small cell lung cancer by regulating miR-21-5p/SOX7 axis

Wang P, Chen D, Ma H, Li Y

OncoTargets and Therapy 2017, 10:5137-5149

Published Date: 25 October 2017

Increased histone deacetylase 6 expression serves as a favorable prognostic factor for diffuse large B-cell lymphoma

Lin X, Cai L, Qian Z, Wang C, Sun N, Sun X, Huang H, Guo W, Lin H, Yao R

OncoTargets and Therapy 2017, 10:5129-5136

Published Date: 24 October 2017

Long noncoding RNA and mRNA profiling in MDA-MB-231 cells following RNAi-mediated knockdown of SIRT7

Chen KL, Li L, Wang YR, Li CM, Badri TM, Wang GL

OncoTargets and Therapy 2017, 10:5115-5128

Published Date: 24 October 2017

Original Research

Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer

Ichiki M, Wataya H, Yamada K, Tsuruta N, Takeoka H, Okayama Y, Sasaki J, Hoshino T

OncoTargets and Therapy 2017, 10:5107-5113

Published Date: 24 October 2017

The matrix metalloproteinase and insulin-like growth factor system in oral cancer – a prospective clinical study

Schiegnitz E, Kämmerer PW, Schön H, Gülle C, Berres M, Sagheb K, Al-Nawas B

OncoTargets and Therapy 2017, 10:5099-5105

Published Date: 24 October 2017

Association of PTEN expression with biochemical recurrence in prostate cancer: results based on previous reports

Xie HJ, Xie B, Liu CY, Wang J, Xu Y

OncoTargets and Therapy 2017, 10:5089-5097

Published Date: 24 October 2017

Developing a novel dual PI3K–mTOR inhibitor from the prodrug of a metabolite

Zhou Y, Zhang GY, Wang F, Wang J, Ding YW, Li XY, Shi CT, Li JK, Shih CK, You S

OncoTargets and Therapy 2017, 10:5077-5087

Published Date: 20 October 2017

FcγRIIA and IIIA polymorphisms predict clinical outcome of trastuzumab-treated metastatic gastric cancer

Wang D, Wei X, Wang Z, Lu Y, Shi S, Wang N, Qiu M, Wang F, Wang RJ, Li Y, Xu R

OncoTargets and Therapy 2017, 10:5065-5076

Published Date: 19 October 2017

Practical management of adverse events associated with cabozantinib treatment in patients with renal-cell carcinoma

Gerendash BS, Creel PA

OncoTargets and Therapy 2017, 10:5053-5064

Published Date: 19 October 2017

Adult acute megakaryoblastic leukemia: rare association with cytopenias of undetermined significance and p210 and p190 BCR–ABL transcripts

Dima D, Oprita L, Rosu AM, Trifa A, Selicean C, Moisoiu V, Frinc I, Zdrenghea M, Tomuleasa C

OncoTargets and Therapy 2017, 10:5047-5051

Published Date: 19 October 2017

Clinical significance of Fusobacterium nucleatum, epithelial–mesenchymal transition, and cancer stem cell markers in stage III/IV colorectal cancer patients

Yan X, Liu L, Li H, Qin H, Sun Z

OncoTargets and Therapy 2017, 10:5031-5046

Published Date: 17 October 2017

Original Research

Impact of prior therapies on everolimus activity: an exploratory analysis of RADIANT-4

Buzzoni R, Carnaghi C, Strosberg J, Fazio N, Singh S, Herbst F, Ridolfi A, Pavel ME, Wolin EM, Valle JW, Oh DY, Yao JC, Pommier R

OncoTargets and Therapy 2017, 10:5013-5030

Published Date: 16 October 2017

Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis

Zhuan-Sun Y, Huang F, Feng M, Zhao X, Chen W, Zhu Z, Zhang S

OncoTargets and Therapy 2017, 10:5005-5012

Published Date: 16 October 2017

Novel strategy of stents in thyroid mass: a case series report of managing severely dyspneic patients

Bhandari A, Wang Y, Lv S, Xia E, Wang O

OncoTargets and Therapy 2017, 10:4997-5004

Published Date: 16 October 2017

Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study

Xu J, Liu X, Yang S, Zhang X, Shi Y

OncoTargets and Therapy 2017, 10:4989-4995

Published Date: 13 October 2017

Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients

Daoud MA, Aboelnaga EM, Alashry MS, Fathy S, Aletreby MA

OncoTargets and Therapy 2017, 10:4981-4988

Published Date: 12 October 2017

Mutation analysis and copy number alterations of KIF23 in non-small-cell lung cancer exhibiting KIF23 over-expression

Vikberg AL, Vooder T, Lokk K, Annilo T, Golovleva I

OncoTargets and Therapy 2017, 10:4969-4979

Published Date: 11 October 2017

Molecular alterations and clinical prognostic factors for cholangiocarcinoma in Thai population

Trachu N, Sirachainan E, Larbcharoensub N, Rattanadech W, Detarkom S, Monnamo N, Kamprerasart K, MunTham D, Sukasem C, Reungwetwattana T

OncoTargets and Therapy 2017, 10:4955-4968

Published Date: 11 October 2017

Upregulation of long noncoding RNA LOC440040 promotes tumor progression and predicts poor prognosis in patients with prostate cancer

Zhang C, Liu C, Wu J, Zheng Y, Xu H, Cheng G, Hua L

OncoTargets and Therapy 2017, 10:4945-4954

Published Date: 11 October 2017

The expression of microRNA-324-3p as a tumor suppressor in nasopharyngeal carcinoma and its clinical significance

Zhang H, Sun Y, Li J, Huang L, Tan S, Yang F, Li H

OncoTargets and Therapy 2017, 10:4935-4943

Published Date: 11 October 2017

Identification of key pathways and genes with aberrant methylation in prostate cancer using bioinformatics analysis

Singh AN, Sharma N

OncoTargets and Therapy 2017, 10:4925-4933

Published Date: 10 October 2017

Low platelet count is potentially the most important contributor to severe bleeding in patients newly diagnosed with acute promyelocytic leukemia

Song Y, Peng P, Qiao C, Zhang R, Li J, Lu H

OncoTargets and Therapy 2017, 10:4917-4924

Published Date: 9 October 2017

NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2

Ding N, Wu H, Tao T, Peng E

OncoTargets and Therapy 2017, 10:4905-4915

Published Date: 6 October 2017

let-7d suppresses proliferation and invasion and promotes apoptosis of meningioma by targeting AEG-1

Li H, Zhao J

OncoTargets and Therapy 2017, 10:4895-4904

Published Date: 6 October 2017

Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib

Koutsoukos K, Bamias A, Tzannis K, Espinosa Montaño M, Bozionelou V, Christodoulou C, Stefanou D, Kalofonos H, Duran I, Papazisis K

OncoTargets and Therapy 2017, 10:4885-4893

Published Date: 6 October 2017

Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents

Ayoub NM, Al-Shami KM, Alqudah MA, Mhaidat NM

OncoTargets and Therapy 2017, 10:4869-4883

Published Date: 5 October 2017

ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy

Song F, Zhang J, Li S, Wu J, Jin T, Qin J, Wang Y, Wang M, Xu J

OncoTargets and Therapy 2017, 10:4859-4867

Published Date: 3 October 2017

TERT-CLPTM1 locus polymorphism (rs401681) is associated with the prognosis of hepatocellular carcinoma

Lee HW, Park W, Heo Y, Park TI, Park SY, Lee J

OncoTargets and Therapy 2017, 10:4853-4858

Published Date: 3 October 2017

Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer

Shi T, Jiang R, Wang P, Xu Y, Yin S, Cheng X, Zang R

OncoTargets and Therapy 2017, 10:4841-4851

Published Date: 3 October 2017

Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta-analysis

Zhang M, Ma H, Zhang J, He L, Ye X, Li X

OncoTargets and Therapy 2017, 10:4829-4839

Published Date: 3 October 2017

Theranostics in nuclear medicine practice

Yordanova A, Eppard E, Kürpig S, Bundschuh RA, Schönberger S, Gonzalez-Carmona M, Feldmann G, Ahmadzadehfar H, Essler M

OncoTargets and Therapy 2017, 10:4821-4828

Published Date: 3 October 2017

Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1

Li S, Yan T, Deng R, Jiang X, Xiong H, Wang Y, Yu Q, Wang X, Chen C, Zhu Y

OncoTargets and Therapy 2017, 10:4809-4819

Published Date: 3 October 2017

Is this the end of cytotoxic chemotherapy in Merkel cell carcinoma?

Rabinowits G

OncoTargets and Therapy 2017, 10:4803-4807

Published Date: 28 September 2017

Clinicopathological features and prognoses in younger and older patients with gastric cancer

Song S, Li C, Li S, Cong X, Xue Y

OncoTargets and Therapy 2017, 10:4795-4802

Published Date: 27 September 2017

Sitting time and occupational and recreational physical activity in relation to the risk of esophageal squamous cell carcinoma

Chen P, Song Q, Han J, Xu H, Chen T, Xu J, Cheng Y

OncoTargets and Therapy 2017, 10:4787-4794

Published Date: 27 September 2017

Yttrium-90 radioembolization of unresectable hepatocellular carcinoma – a single center experience

Meyer C, Pieper CC, Ahmadzadehfar H, Lampe NA, Matuschek EME, Maschke TA, Enkirch SJ, Essler M, Spengler U, Schild HH

OncoTargets and Therapy 2017, 10:4773-4785

Published Date: 26 September 2017

Molecular classification of esophagogastric junction carcinoma correlated with prognosis

Zou L, Wu Y, Ma K, Fan Y, Dong D, Geng N, Li E

OncoTargets and Therapy 2017, 10:4765-4772

Published Date: 25 September 2017

HOXD-AS1 functions as an oncogenic ceRNA to promote NSCLC cell progression by sequestering miR-147a

Wang Q, Jiang S, Song A, Hou S, Wu Q, Qi L, Gao X

OncoTargets and Therapy 2017, 10:4753-4763

Published Date: 28 September 2017

DNA hypermethylated status and gene expression of PAX1/SOX1 in patients with colorectal carcinoma

Huang J, Tan ZR, Yu J, Li H, Lv Q, Shao Y, Zhou H

OncoTargets and Therapy 2017, 10:4739-4751

Published Date: 26 September 2017

Characteristics and mutation analysis of Ph-positive leukemia patients with T315I mutation receiving tyrosine kinase inhibitors

Xu PP, Guo D, Shao XY, Peng MX, Chen B

OncoTargets and Therapy 2017, 10:4731-4738

Published Date: 25 September 2017

Quercetin inhibits epithelial–mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial–mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells

Yu D, Ye T, Xiang Y, Shi Z, Zhang J, Lou B, Zhang F, Chen B, Zhou M

OncoTargets and Therapy 2017, 10:4719-4729

Published Date: 25 September 2017

Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors

Ma Z, Huang H, Xu Y, He X, Wang J, Hui B, Ji H, Zhou J, Wang K

OncoTargets and Therapy 2017, 10:4711-4717

Published Date: 25 September 2017

RNAi-mediated knockdown of CAIX enhances the radiosensitivity of nasopharyngeal carcinoma cell line, CNE-2

Jiang L, Xu G, Li Z, Zeng X, Li Z, Liu J, Mei L, Li X

OncoTargets and Therapy 2017, 10:4701-4709

Published Date: 25 September 2017

High expression of Sam68 in sacral chordomas is associated with worse clinical outcomes

Wen H, Li P, Ma H, Zheng J, Yu Y, Lv G

OncoTargets and Therapy 2017, 10:4691-4700

Published Date: 22 September 2017

Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature review

Zhang Y, Qi Y, Wang A, Ma B, Fu X, Zhao L, Gao Q

OncoTargets and Therapy 2017, 10:4687-4690

Published Date: 22 September 2017

Targeting the androgen receptor in triple-negative breast cancer: current perspectives

Mina A, Yoder R, Sharma P

OncoTargets and Therapy 2017, 10:4675-4685

Published Date: 20 September 2017

Clinical significance of SLP-2 in hepatocellular carcinoma tissues and its regulation in cancer cell proliferation, migration, and EMT

Huang Y, Chen Y, Lin X, Lin Q, Han M, Guo G

OncoTargets and Therapy 2017, 10:4665-4673

Published Date: 20 September 2017

DNA ploidy and S-phase fraction analysis in peritoneal carcinomatosis from ovarian cancer: correlation with clinical pathological factors and response to chemotherapy

Carloni S, Gallerani G, Tesei A, Scarpi E, Verdecchia GM, Virzì S, Fabbri F, Arienti C

OncoTargets and Therapy 2017, 10:4657-4664

Published Date: 20 September 2017

The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis

Pang Q, Jin H, Qu K, Man Z, Wang Y, Yang S, Zhou L, Liu H

OncoTargets and Therapy 2017, 10:4645-4656

Published Date: 20 September 2017

HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma

Maroto P, Esteban E, Fernández Parra E, Mendez-Vidal MJ, Domenech M, Pérez-Valderrama B, Calderero V, Pérez-Gracia JL, Grande E, Algaba F

OncoTargets and Therapy 2017, 10:4635-4643

Published Date: 20 September 2017

NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy

Chang B, Park MJ, Choi SI, In KH, Kim CH, Lee SH

OncoTargets and Therapy 2017, 10:4625-4633

Published Date: 19 September 2017

The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and -9 in angiogenesis, metastasis, and prognosis of endometrial cancer

Mahecha AM, Wang H

OncoTargets and Therapy 2017, 10:4617-4624

Published Date: 19 September 2017

Effect of temozolomide on survival in elderly patients with glioblastoma and impaired performance status: a propensity score-matching analysis [Corrigendum]

Liu Y, Liu P, Shao W, Du H, Li Z, Guo C, Li Z

OncoTargets and Therapy 2017, 10:4615-4616

Published Date: 18 September 2017

EGFR with TKI-sensitive mutations in exon 19 is highly expressed and frequently detected in Chinese patients with lung squamous carcinoma

Memon AA, Zhang HP, Gu Y, Luo Q, Shi JJ, Deng Z, Ma J, Ma W

OncoTargets and Therapy 2017, 10:4607-4613

Published Date: 18 September 2017

Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy

Sunakawa Y, Izawa N, Mizukami T, Horie Y, Hirakawa M, Arai H, Ogura T, Tsuda T, Nakajima TE

OncoTargets and Therapy 2017, 10:4599-4605

Published Date: 15 September 2017

Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis

Meng Q, Shi S, Liang C, Liang D, Xu W, Ji S, Zhang B, Ni Q, Xu J, Yu X

OncoTargets and Therapy 2017, 10:4591-4598

Published Date: 15 September 2017

DNA fragmentation factors 40 and 45 (DFF40/DFF45) and B-cell lymphoma 2 (Bcl-2) protein are underexpressed in uterine leiomyosarcomas and may predict survival

Banas T, Pitynski K, Okon K, Czerw A

OncoTargets and Therapy 2017, 10:4579-4589

Published Date: 14 September 2017

Polygonatum odoratum lectin promotes BECN1 expression and induces autophagy in malignant melanoma by regulation of miR1290

Luan W, Qian Y, Ni X, Chanda TK, Xia Y, Wang J, Yan Y, Xu B

OncoTargets and Therapy 2017, 10:4569-4577

Published Date: 14 September 2017

CYP19A1 gene polymorphism and colorectal cancer etiology in Saudi population: case–control study

Al-Mukaynizi FB, Alanazi M, Al-Daihan S, Parine NR, Almadi M, Aljebreen A, Azzam N, Alharbi O, Arafah M, Warsy A

OncoTargets and Therapy 2017, 10:4559-4567

Published Date: 14 September 2017

Case report of a KIT-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapy

Luo C, Shen JY, Ying J, Fang XH, Wang XH, Fu ZX, Liu P

OncoTargets and Therapy 2017, 10:4553-4557

Published Date: 14 September 2017

Clinicopathological significance of HSP27 in gastric cancer: a meta-analysis

Ge H, He X, Guo L, Yang X

OncoTargets and Therapy 2017, 10:4543-4551

Published Date: 13 September 2017

Anaplastic lymphoma kinase inhibition in metastatic non-small cell lung cancer: clinical impact of alectinib

Muller IB, de Langen AJ, Giovannetti E, Peters GJ

OncoTargets and Therapy 2017, 10:4535-4541

Published Date: 13 September 2017

Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer

Tang Y, Qiao G, Xu E, Xuan Y, Liao M, Yin G

OncoTargets and Therapy 2017, 10:4527-4534

Published Date: 12 September 2017

Adenocarcinoma of the lung with EGFR gene mutation and subsequent resistance mechanisms exploration: case report

Xu L, Wang QZ, Wu L

OncoTargets and Therapy 2017, 10:4517-4525

Published Date: 12 September 2017

The non-small cell lung cancer EGFR extracellular domain mutation, M277E, is oncogenic and drug-sensitive

Yu S, Zhang Y, Pan YJ, Cheng C, Sun YH, Chen HQ

OncoTargets and Therapy 2017, 10:4507-4515

Published Date: 12 September 2017

Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy

Liao X, Huang K, Huang R, Liu X, Han C, Yu L, Yu T, Yang C, Wang X, Peng T

OncoTargets and Therapy 2017, 10:4493-4506

Published Date: 12 September 2017

Predictive factors and prognosis for recurrent laryngeal nerve invasion in papillary thyroid carcinoma

Chen W, Lei J, You J, Lei Y, Li Z, Gong R, Tang H, Zhu J

OncoTargets and Therapy 2017, 10:4485-4491

Published Date: 11 September 2017

Cervical level IIb metastases in squamous cell carcinoma of the oral cavity: a systematic review and meta-analysis

Kou Y, Zhao T, Huang S, Liu J, Duan W, Wang Y, Wang Z, Li D, Ning C, Sun C

OncoTargets and Therapy 2017, 10:4475-4483

Published Date: 11 September 2017

Oncogenic role of microRNA-20a in human multiple myeloma

Wang T, Tao W, Zhang L, Li SL

OncoTargets and Therapy 2017, 10:4465-4474

Published Date: 11 September 2017

miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells

Li X, Li Y, Wan L, Chen R, Chen F

OncoTargets and Therapy 2017, 10:4455-4464

Published Date: 11 September 2017

Targeted interfering DEP domain containing 1 protein induces apoptosis in A549 lung adenocarcinoma cells through the NF-κB signaling pathway

Wang Q, Li A, Jin J, Huang G

OncoTargets and Therapy 2017, 10:4443-4454

Published Date: 11 September 2017

Intraoperative measurement of thyroglobulin in lymph node aspirates for the detection of metastatic papillary thyroid carcinoma

Wang Y, Liu Y, Wang X, Li X, Jiang R, He X

OncoTargets and Therapy 2017, 10:4435-4441

Published Date: 11 September 2017

Prognostic immune-related gene models for breast cancer: a pooled analysis

Zhao J, Wang Y, Lao Z, Liang S, Hou J, Yu Y, Yao H, You N, Chen K

OncoTargets and Therapy 2017, 10:4423-4433

Published Date: 11 September 2017

Targeted inhibition of the phosphoinositide 3-kinase impairs cell proliferation, survival, and invasion in colon cancer

Yang F, Gao JY, Chen H, Du ZH, Zhang XQ, Gao W

OncoTargets and Therapy 2017, 10:4413-4422

Published Date: 11 September 2017

Marketed drugs used for the management of hypercholesterolemia as anticancer armament

Papanagnou P, Stivarou T, Papageorgiou I, Papadopoulos GE, Pappas A

OncoTargets and Therapy 2017, 10:4393-4411

Published Date: 8 September 2017

Downregulation of DEPTOR inhibits the proliferation, migration, and survival of osteosarcoma through PI3K/Akt/mTOR pathway

Hu B, Lv X, Gao F, Chen S, Wang S, Qing X, Liu J, Wang B, Shao Z

OncoTargets and Therapy 2017, 10:4379-4391

Published Date: 8 September 2017

Genetic variants in long noncoding RNA H19 contribute to the risk of breast cancer in a southeast China Han population

Lin Y, Fu F, Chen Y, Qiu W, Lin S, Yang P, Huang M, Wang C

OncoTargets and Therapy 2017, 10:4369-4378

Published Date: 7 September 2017

Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt’s lymphoma and acute lymphoblastic leukemia

Weagel EG, Meng W, Townsend MH, Velazquez EJ, Brog RA, Boyer MW, Weber KS, Robison RA, O'Neill KL

OncoTargets and Therapy 2017, 10:4355-4367

Published Date: 6 September 2017

Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report

Jovanovic D, Stevic R, Velinovic M, Kontic M, Maric D, Spasic J, Radosavljevic D

OncoTargets and Therapy 2017, 10:4347-4354

Published Date: 6 September 2017

Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma

Zhang MC, Yan ZL, Wang JJ, Yao XQ

OncoTargets and Therapy 2017, 10:4339-4346

Published Date: 1 September 2017

Inhibitory effects of a selective Jak2 inhibitor on adrenocorticotropic hormone production and proliferation of corticotroph tumor AtT20 cells

Asari Y, Kageyama K, Nakada Y, Tasso M, Takayasu S, Niioka K, Ishigame N, Daimon M

OncoTargets and Therapy 2017, 10:4329-4338

Published Date: 1 September 2017

Clinicopathological and prognostic significance of Ki-67 immunohistochemical expression in gastric cancer: a systematic review and meta-analysis

Liu G, Xiong DS, Zeng JJ, Chen BR, Huang ZJ

OncoTargets and Therapy 2017, 10:4321-4328

Published Date: 1 September 2017

The role and significance of VEGFR2+ regulatory T cells in tumor immunity

Zhu PR, Hu CX, Hui KY, Jiang XD

OncoTargets and Therapy 2017, 10:4315-4319

Published Date: 1 September 2017

Nuclear factor-kappa B1 inhibits early apoptosis of glioma cells by promoting the expression of Bcl-2

Yang TQ, Chen M, Wang YQ, Xu W, Han Y, Xu J, Xiang YJ, Yuan B, Wang HZ, Zhou YX

OncoTargets and Therapy 2017, 10:4305-4313

Published Date: 31 August 2017

Improvement of survival for non-small cell lung cancer over time

Xia W, Yu X, Mao Q, Xia W, Wang A, Dong G, Chen B, Ma W, Xu L, Jiang F

OncoTargets and Therapy 2017, 10:4295-4303

Published Date: 29 August 2017

Synaptotagmin-7 is overexpressed in hepatocellular carcinoma and regulates hepatocellular carcinoma cell proliferation via Chk1–p53 signaling

Jin H, Xu G, Zhang Q, Pang Q, Fang M

OncoTargets and Therapy 2017, 10:4283-4293

Published Date: 29 August 2017

Comparison of autogeneic and allogeneic natural killer cells immunotherapy on the clinical outcome of recurrent breast cancer

Liang S, Xu K, Niu L, Wang X, Liang Y, Zhang M, Chen J, Lin M

OncoTargets and Therapy 2017, 10:4273-4281

Published Date: 28 August 2017

Apatinib in the treatment of advanced lung adenocarcinoma with KRAS mutation

Zeng D, Wang C, Huang J, Jiang J

OncoTargets and Therapy 2017, 10:4269-4272

Published Date: 28 August 2017

Continuous EGFR tyrosine kinase inhibitor treatment with or without chemotherapy beyond gradual progression in non-small cell lung cancer patients

Peng L, Wang YN, Tang YM, Zeng L, Liu JF, Zeng Z, Liu J, Shi P, Ye XH, Zhao Q

OncoTargets and Therapy 2017, 10:4261-4267

Published Date: 28 August 2017

LEF1-AS1, a long non-coding RNA, promotes malignancy in glioblastoma

Wang J, Liu X, Yan C, Liu J, Wang S, Hong Y, Gu A, Zhao P

OncoTargets and Therapy 2017, 10:4251-4260

Published Date: 28 August 2017

Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors

Creelan BC, Gabrilovich DI, Gray JE, Williams CC, Tanvetyanon T, Haura EB, Weber JS, Gibney GT, Markowitz J, Proksch JW, Reisman SA, McKee MD, Chin MP, Meyer CJ, Antonia SJ

OncoTargets and Therapy 2017, 10:4239-4250

Published Date: 29 August 2017

miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples

Braicu OL, Budisan L, Buiga R, Jurj A, Achimas-Cadariu P, Pop LA, Braicu C, Irimie A, Berindan-Neagoe I

OncoTargets and Therapy 2017, 10:4225-4238

Published Date: 28 August 2017

Initial experience of correlating diffusion spectral parameters with histopathologic indexes in murine colorectal tumor homografts

Zhang XY, Li XT, Sun J, Sun YS

OncoTargets and Therapy 2017, 10:4213-4223

Published Date: 26 August 2017

HPIP: a predictor of lymph node metastasis and poor survival in cervical cancer

Cao S, Sun J, Lin S, Zhao L, Wu D, Liang T, Sheng W

OncoTargets and Therapy 2017, 10:4205-4211

Published Date: 26 August 2017

Investigation of proliferation and migration of tongue squamous cell carcinoma promoted by three chemokines, MIP-3α, MIP-1β, and IP-10

Chu H, Jia B, Qiu X, Pan J, Sun X, Wang Z, Zhao J

OncoTargets and Therapy 2017, 10:4193-4203

Published Date: 29 August 2017

Clinical applications of dendritic cells–cytokine-induced killer cells mediated immunotherapy for pancreatic cancer: an up-to-date meta-analysis

Zhang YC, Zhang X, Zhang AQ, Li K, Qu K

OncoTargets and Therapy 2017, 10:4173-4192

Published Date: 23 August 2017

miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer

Ma M, Chen S, Liu Z, Xie H, Deng H, Shang S, Wang X, Xia M, Zuo C

OncoTargets and Therapy 2017, 10:4161-4171

Published Date: 22 August 2017

AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells

Lee D, Yu EJ, Ham I, Hur H, Kim Y

OncoTargets and Therapy 2017, 10:4153-4159

Published Date: 22 August 2017

RASSF1A hypermethylation is associated with ASXL1 mutation and indicates an adverse outcome in non-M3 acute myeloid leukemia

Liu F, Gong M, Gao L, Cai X, Zhang H, Ma Y

OncoTargets and Therapy 2017, 10:4143-4151

Published Date: 22 August 2017

Survival significance of epidermal growth factor receptor tyrosine kinase inhibitors and current staging system for survival after recurrence in patients with completely resected lung adenocarcinoma

Saji H, Sakai H, Kimura H, Miyazawa T, Marushima H, Nakamura H

OncoTargets and Therapy 2017, 10:4135-4141

Published Date: 21 August 2017

Case report

Response to crizotinib in a lung adenocarcinoma patient harboring a novel SLC34A2-ROS1 fusion variant

Zhao Z, Song ZJ, Wang XW, Sun HF, Yang XM, Yuan Y, Yu P

OncoTargets and Therapy 2017, 10:4129-4133

Published Date: 21 August 2017

Osteopontin and vasculogenic mimicry formation are associated with response to neoadjuvant chemotherapy in advanced breast cancer

Gu M, Zheng X

OncoTargets and Therapy 2017, 10:4121-4127

Published Date: 18 August 2017

Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer

Chen Y, Tang W, Pan X, Wu C, Cao Y, Yang W

OncoTargets and Therapy 2017, 10:4113-4119

Published Date: 17 August 2017

Clinicopathologic characteristics, therapy and outcomes of patients with primary ureteral small cell carcinoma: a case series and systematic review of the literature

Zhong W, Lin R, Zhang L, Jin C, Li X, He Q, Gong K, He Z, Zhou L

OncoTargets and Therapy 2017, 10:4105-4111

Published Date: 17 August 2017

Chest reconstruction using a custom-designed polyethylene 3D implant after resection of the sternal manubrium

Lipińska J, Kutwin L, Wawrzycki M, Olbrzymek L, Jabłoński S

OncoTargets and Therapy 2017, 10:4099-4103

Published Date: 17 August 2017

Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer: patient selection and special considerations

Patel SA, Hoffman-Censits J

OncoTargets and Therapy 2017, 10:4089-4098

Published Date: 17 August 2017

CT-guided 125I interstitial brachytherapy for pelvic recurrent cervical carcinoma after radiotherapy

Tong L, Liu P, Huo B, Guo Z, Ni H

OncoTargets and Therapy 2017, 10:4081-4088

Published Date: 17 August 2017

Carcinogenicity of chromium and chemoprevention: a brief update

Wang Y, Su H, Gu Y, Song X, Zhao J

OncoTargets and Therapy 2017, 10:4065-4079

Published Date: 16 August 2017

The role of desmosomes in carcinogenesis

Zhou G, Yang L, Gray A, Srivastava AK, Li C, Zhang G, Cui T

OncoTargets and Therapy 2017, 10:4059-4063

Published Date: 14 August 2017

Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer

Lv RB, Wang QG, Liu C, Liu F, Zhao Q, Han JG, Ren DL, Liu B, Li CL

OncoTargets and Therapy 2017, 10:4051-4057

Published Date: 14 August 2017

An integrated analysis for long noncoding RNAs and microRNAs with the mediated competing endogenous RNA network in papillary renal cell carcinoma

Huang CG, Yuan NJ, Wu LY, Wang XF, Dai JQ, Song P, Li FX, Xu CB, Zhao XH

OncoTargets and Therapy 2017, 10:4037-4050

Published Date: 14 August 2017

Effect of temozolomide on survival in elderly patients with glioblastoma and impaired performance status: a propensity score–matching analysis

Liu Y, Liu P, Shao W, Du H, Li Z, Guo C, Li Z

OncoTargets and Therapy 2017, 10:4029-4035

Published Date: 14 August 2017

Low concentration of quercetin antagonizes the invasion and angiogenesis of human glioblastoma U251 cells

Liu Y, Tang Z, Yang J, Zhou Y, Meng L, Wang H, Li C

OncoTargets and Therapy 2017, 10:4023-4028

Published Date: 11 August 2017

Perihippocampal metastasis following hippocampus-avoiding prophylactic cranial irradiation for small cell lung cancer: a case report

Yeo SG

OncoTargets and Therapy 2017, 10:4017-4021

Published Date: 11 August 2017

Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy

Chen L, Hao Y, Zhu LH, Li S, Zuo YJ, Zhang YX, Song HJ, Xue YW

OncoTargets and Therapy 2017, 10:4007-4016

Published Date: 10 August 2017

Clinical significance and prospective molecular mechanism of MALAT1 in pancreatic cancer exploration: a comprehensive study based on the GeneChip, GEO, Oncomine, and TCGA databases

Xie ZC, Dang YW, Wei DM, Chen P, Tang RX, Huang Q, Liu JH, Luo DZ

OncoTargets and Therapy 2017, 10:3991-4005

Published Date: 10 August 2017

Enhancement of antitumor activity by using a fully human gene encoding a single-chain fragmented antibody specific for carcinoembryonic antigen

Shibaguchi H, Luo N, Shirasu N, Kuroki M, Kuroki M

OncoTargets and Therapy 2017, 10:3979-3990

Published Date: 22 August 2017

Fucosyltransferase VII promotes proliferation via the EGFR/AKT/mTOR pathway in A549 cells

Liang J, Gao W, Cai L

OncoTargets and Therapy 2017, 10:3971-3978

Published Date: 7 August 2017

Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma

Li J, Wang L

OncoTargets and Therapy 2017, 10:3965-3969

Published Date: 7 August 2017

Therapies for acute myeloid leukemia: vosaroxin

Sayar H, Bashardoust P

OncoTargets and Therapy 2017, 10:3957-3963

Published Date: 7 August 2017

Fibrous sheath interacting protein 1 overexpression is associated with unfavorable prognosis in bladder cancer: a potential therapeutic target

Sun M, Zhao W, Zeng Y, Zhang D, Chen Z, Liu C, Wu B

OncoTargets and Therapy 2017, 10:3949-3956

Published Date: 7 August 2017

NRAS-mutant melanoma: current challenges and future prospect

Muñoz-Couselo E, Zamora Adelantado E, Ortiz C, Soberino García J, Perez-Garcia J

OncoTargets and Therapy 2017, 10:3941-3947

Published Date: 8 August 2017

Bystander signaling via oxidative metabolism

Sawal HA, Asghar K, Bureik M, Jalal N

OncoTargets and Therapy 2017, 10:3925-3940

Published Date: 4 August 2017

Prognosis of neutrophil-to-lymphocyte ratio in clinical early-stage tongue (cT1/T2N0) cancer

Wu CN, Chuang HC, Lin YT, Fang FM, Li SH, Chien CY

OncoTargets and Therapy 2017, 10:3917-3924

Published Date: 4 August 2017

Clinicopathological and prognostic significance of circulating tumor cells in patients with head and neck cancer: a meta-analysis

Sun T, Zou K, Yuan Z, Yang C, Lin X, Xiong B

OncoTargets and Therapy 2017, 10:3907-3916

Published Date: 4 August 2017

microRNA-130a is an oncomir suppressing the expression of CRMP4 in gastric cancer

Zhou Y, Li R, Yu H, Wang R, Shen Z

OncoTargets and Therapy 2017, 10:3893-3905

Published Date: 3 August 2017

SHP2 overexpression enhances the invasion and metastasis of ovarian cancer in vitro and in vivo

Hu ZQ, Li J, Gao Q, Wei S, Yang B

OncoTargets and Therapy 2017, 10:3881-3891

Published Date: 2 August 2017

A practical guide to the handling and administration of talimogene laherparepvec in Europe

Harrington KJ, Michielin O, Malvehy J, Pezzani Grüter I, Grove L, Frauchiger AL, Dummer R

OncoTargets and Therapy 2017, 10:3867-3880

Published Date: 2 August 2017

IGF2BP3 as a potential tissue marker for the diagnosis of esophageal high-grade intraepithelial neoplasia

Zhang JJ, Ji Q, Jiao CH, Ren LH, Zhao Y, Chen YF, Shi RH, Feng YD

OncoTargets and Therapy 2017, 10:3861-3866

Published Date: 1 August 2017

Outcomes of adding induction chemotherapy to concurrent chemoradiotherapy for stage T3N0-1 nasopharyngeal carcinoma: a propensity-matched study

Lan XW, Xiao Y, Zou XB, Zhang XM, OuYang PY, Xie FY

OncoTargets and Therapy 2017, 10:3853-3860

Published Date: 1 August 2017

Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma

Liu W, Hu J, Zhou K, Chen F, Wang Z, Liao B, Dai Z, Cao Y, Fan J, Zhou J

OncoTargets and Therapy 2017, 10:3843-3851

Published Date: 1 August 2017

The effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCT

Sun HL, Ni JY, Jiang XY, Chen D, Chen YT, Xu LF

OncoTargets and Therapy 2017, 10:3835-3842

Published Date: 1 August 2017

Elevated expression of neuropilin-2 associated with unfavorable prognosis in hepatocellular carcinoma

Dong X, Guo W, Zhang S, Wu T, Sun Z, Yan S, Zheng S

OncoTargets and Therapy 2017, 10:3827-3833

Published Date: 31 July 2017

CD155 expression and its correlation with clinicopathologic characteristics, angiogenesis, and prognosis in human cholangiocarcinoma

Huang DW, Huang M, Lin XS, Huang Q

OncoTargets and Therapy 2017, 10:3817-3825

Published Date: 31 July 2017

Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer

Roviello G, Corona SP, Bonetta A, Cappelletti MR, Generali D

OncoTargets and Therapy 2017, 10:3811-3815

Published Date: 31 July 2017

The RANK/RANKL/OPG system in tumorigenesis and metastasis of cancer stem cell: potential targets for anticancer therapy

Sisay M, Mengistu G, Edessa D

OncoTargets and Therapy 2017, 10:3801-3810

Published Date: 27 July 2017

Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival

Peng JH, Li H, Ou QJ, Lin JZ, Wu XJ, Lu ZH, Yuan YF, Wan DS, Fang YJ, Pan ZZ

OncoTargets and Therapy 2017, 10:3789-3799

Published Date: 27 July 2017

Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas

Wu M, Wanggou S, Li X, Liu Q, Xie Y

OncoTargets and Therapy 2017, 10:3781-3788

Published Date: 27 July 2017

MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects

Hua WF, Zhang A, Duan P, Zhu J, Zhao Y, He J, Zhang Z

OncoTargets and Therapy 2017, 10:3773-3780

Published Date: 27 July 2017

Volumetric modulated arc therapy for treatment of solid tumors: current insights

Macchia G, Deodato F, Cilla S, Cammelli S, Guido A, Ferioli M, Siepe G, Valentini V, Morganti AG, Ferrandina G

OncoTargets and Therapy 2017, 10:3755-3772

Published Date: 26 July 2017

KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity

Xie ZH, Yu J, Shang L, Zhu YQ, Hao JJ, Cai Y, Xu X, Zhang Y, Wang MR

OncoTargets and Therapy 2017, 10:3743-3754

Published Date: 26 July 2017

Foxj2 overexpression is associated with poor prognosis, progression, and metastasis in nasopharyngeal carcinoma

Shan Y, Chang T, Shi S, Tang M, Bao L, Li L, You B, You Y

OncoTargets and Therapy 2017, 10:3733-3741

Published Date: 24 July 2017

Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma

Liao X, Huang R, Liu X, Han C, Yu L, Wang SJ, Sun N, Li B, Ning X, Peng T

OncoTargets and Therapy 2017, 10:3719-3732

Published Date: 24 July 2017

The prognostic value of decreased miR-101 in various cancers: a meta-analysis of 12 studies

Hu J, Wu C, Zhao X, Liu C

OncoTargets and Therapy 2017, 10:3709-3718

Published Date: 24 July 2017

Emerging role of nivolumab in the management of patients with non-small-cell lung cancer: current data and future perspectives

Feld E, Horn L

OncoTargets and Therapy 2017, 10:3697-3708

Published Date: 24 July 2017

miR-203 as a novel biomarker for the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis

Ye H, Hao H, Wang J, Chen R, Huang Z

OncoTargets and Therapy 2017, 10:3685-3696

Published Date: 21 July 2017

Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study

Gao L, Li SH, Tian YX, Zhu QQ, Chen G, Pang YY, Hu XH

OncoTargets and Therapy 2017, 10:3667-3683

Published Date: 20 July 2017

Clinical targeting recombinant immunotoxins for cancer therapy

Li M, Liu ZS, Liu XL, Hui Q, Lu SY, Qu LL, Li YS, Zhou Y, Ren HL, Hu P

OncoTargets and Therapy 2017, 10:3645-3665

Published Date: 20 July 2017

Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemia

Guo H, Zhang T, Wen X, Zhou JD, Ma J, An C, Zhang W, Xu Z, Lin J, Qian J

OncoTargets and Therapy 2017, 10:3635-3644

Published Date: 20 July 2017

Prognostic and predictive values of PD-L1 expression in patients with digestive system cancer: a meta-analysis

Dai C, Wang M, Lu J, Dai Z, Lin S, Yang P, Tian T, Liu X, Min WL, Dai Z

OncoTargets and Therapy 2017, 10:3625-3634

Published Date: 21 July 2017

A systematic comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages between concurrent chemoradiotherapy and sequential chemotherapy

Qian M, Tao HM, Xu W, Ji HZ

OncoTargets and Therapy 2017, 10:3617-3623

Published Date: 20 July 2017

Impact of combined treatment with nimesulide and cisplatin on oral carcinoma cells

Barac A, Mitulovic G, Hallström S, Zehetmayer S, Grasl MC, Erovic BM

OncoTargets and Therapy 2017, 10:3607-3616

Published Date: 19 July 2017

Original Research

Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysis

Fan QW, Liu BR

OncoTargets and Therapy 2017, 10:3591-3606

Published Date: 19 July 2017

Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo

Lu JJ, Xu Y, Zhao Z, Ke XN, Wei X, Kang J, Zong X, Mao HL, Liu PS

OncoTargets and Therapy 2017, 10:3579-3589

Published Date: 19 July 2017

Review

Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia – role of blinatumomab

Queudeville M, Handgretinger R, Ebinger M

OncoTargets and Therapy 2017, 10:3567-3578

Published Date: 19 July 2017

The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy

Wang Y, Hu GF, Wang ZH

OncoTargets and Therapy 2017, 10:3557-3566

Published Date: 19 July 2017

Combined detection of dickkopf-1 subtype classification autoantibodies as biomarkers for the diagnosis and prognosis of non-small cell lung cancer

Shen L, Wu X, Tan J, Gu M, Teng Y, Wang Z, Yue W

OncoTargets and Therapy 2017, 10:3545-3556

Published Date: 18 July 2017

Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer

Pan HW, Su HH, Hsu C, Huang GJ, Wu TT

OncoTargets and Therapy 2017, 10:3531-3543

Published Date: 17 July 2017

Circ-104916 is downregulated in gastric cancer and suppresses migration and invasion of gastric cancer cells

Li J, Zhen L, Zhang Y, Zhao L, Liu H, Cai D, Chen H, Yu J, Qi X, Li G

OncoTargets and Therapy 2017, 10:3521-3529

Published Date: 17 July 2017

Analysis of clinical characteristics and efficacy of chronic myeloid leukemia onset with extreme thrombocytosis in the era of tyrosine kinase inhibitors

Liu Z, Fan H, Li Y, Liu C

OncoTargets and Therapy 2017, 10:3515-3520

Published Date: 17 July 2017

Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer

Heerma van Voss MR, Vesuna F, Bol GM, Meeldijk J, Raman A, Offerhaus GJ, Buerger H, Patel AH, van der Wall E, van Diest PJ, Raman V

OncoTargets and Therapy 2017, 10:3501-3513

Published Date: 17 July 2017

An evaluation of the clinical diagnostic value of contrast-enhanced ultrasound combined with contrast-enhanced computed tomography in space-occupying lesions of the kidney

Tian W, Lu JB, Jiao D, Cong ZB

OncoTargets and Therapy 2017, 10:3493-3499

Published Date: 14 July 2017

Interleukin-35 as a predictor of prostate cancer in patients undergoing initial prostate biopsy

Zhou CC, Zhang J, Chen Y, Wang H, Hou JQ

OncoTargets and Therapy 2017, 10:3485-3491

Published Date: 14 July 2017

Association between polymorphisms in DNA repair gene XRCC1 and non-melanoma skin cancer risk: a meta-analysis

Wang L, Xu J, Duan B

OncoTargets and Therapy 2017, 10:3475-3483

Published Date: 13 July 2017

Ergosterol peroxide inhibits ovarian cancer cell growth through multiple pathways

Tan W, Pan M, Liu H, Tian H, Ye Q, Liu H

OncoTargets and Therapy 2017, 10:3467-3474

Published Date: 13 July 2017

PD-1 blockade restores impaired function of ex vivo expanded CD8+ T cells and enhances apoptosis in mismatch repair deficient EpCAM+PD-L1+ cancer cells

Kumar R, Yu F, Zhen YH, Li B, Wang J, Yang Y, Ge HX, Hu P, Xiu J

OncoTargets and Therapy 2017, 10:3453-3465

Published Date: 13 July 2017

Recent progress on the effects of microRNAs and natural products on tumor epithelial–mesenchymal transition

He SJ, Xiang CQ, Zhang Y, Lu XT, Chen HW, Xiong LX

OncoTargets and Therapy 2017, 10:3435-3451

Published Date: 12 July 2017

Evaluation of p53 gene expression and prognosis characteristics in uveal melanoma cases

Liu H, Zhou M

OncoTargets and Therapy 2017, 10:3429-3434

Published Date: 12 July 2017

RNA sequencing identifies gene expression profile changes associated with β-estradiol treatment in U2OS osteosarcoma cells

Chen B, Liu Z, Zhang J, Wang H, Yu B

OncoTargets and Therapy 2017, 10:3421-3427

Published Date: 11 July 2017

A comprehensive insight into the clinicopathologic significance of miR-144-3p in hepatocellular carcinoma

Liang HW, Ye ZH, Yin SY, Mo WJ, Wang HL, Zhao JC, Liang GM, Feng ZB, Chen G, Luo DZ

OncoTargets and Therapy 2017, 10:3405-3419

Published Date: 11 July 2017

ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma

Mao Y, Wu S

OncoTargets and Therapy 2017, 10:3399-3404

Published Date: 11 July 2017

Prognostic role of lymphocyte to monocyte ratio for patients with pancreatic cancer: a systematic review and meta-analysis

Li W, Tao L, Zhang L, Xiu D

OncoTargets and Therapy 2017, 10:3391-3397

Published Date: 11 July 2017

Sex-related differences in clinicopathological features and survival of patients with primary urethral carcinoma: a population-based study

Wei Y, Wu YP, Xu N, Li XD, Chen SH, Cai H, Zheng QS, Xue XY

OncoTargets and Therapy 2017, 10:3381-3389

Published Date: 10 July 2017

The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia

Aberuyi N, Rahgozar S, Khosravi Dehaghi Z, Moafi A, Masotti A, Paolini A

OncoTargets and Therapy 2017, 10:3373-3380

Published Date: 10 July 2017

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Kourie HR, El Rassy E, Clatot F, de Azambuja E, Lambertini M

OncoTargets and Therapy 2017, 10:3363-3372

Published Date: 10 July 2017

The long noncoding RNA, TINCR, functions as a competing endogenous RNA to regulate PDK1 expression by sponging miR-375 in gastric cancer

Chen ZL, Liu H, Yang HL, Gao YK, Zhang GW, Hu JJ

OncoTargets and Therapy 2017, 10:3353-3362

Published Date: 10 July 2017

Preoperative serum carcinoembryonic antigen levels are associated with histologic subtype, EGFR mutations, and ALK fusion in patients with completely resected lung adenocarcinoma

Wang Z, Yang S, Lu H

OncoTargets and Therapy 2017, 10:3345-3351

Published Date: 7 July 2017

Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer

Guo Y, Shi JJ, Zhang J, Li HX, Liu B, Guo H

OncoTargets and Therapy 2017, 10:3337-3344

Published Date: 7 July 2017

Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3-4 nasopharyngeal carcinoma

Xue F, Hu C, He X

OncoTargets and Therapy 2017, 10:3329-3336

Published Date: 6 July 2017

Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cells

Woitok M, Klose D, Di Fiore S, Richter W, Stein C, Gresch G, Grieger E, Barth S, Fischer R, Kolberg K, Niesen J

OncoTargets and Therapy 2017, 10:3313-3327

Published Date: 6 July 2017

Conventional real-time PCR-based detection of T790M using tumor tissue or blood in patients with EGFR TKI-resistant NSCLC

Wu Y, Tong R, Zhang Y, Hu B, Zheng K, Ding Z, Peng F, Gong Y, Liu Y, Lu Y

OncoTargets and Therapy 2017, 10:3307-3312

Published Date: 5 July 2017

Novel agents for the treatment of childhood leukemia: an update

Eryılmaz E, Canpolat C

OncoTargets and Therapy 2017, 10:3299-3306

Published Date: 4 July 2017

Reactive oxygen species mediate soft corals-derived sinuleptolide-induced antiproliferation and DNA damage in oral cancer cells

Chang YT, Huang C, Tang J, Liaw C, Li R, Liu J, Sheu J, Chang HW

OncoTargets and Therapy 2017, 10:3289-3297

Published Date: 4 July 2017

Primary lung sarcoma treated with stereotactic ablative radiotherapy: a case report

Yeo SG

OncoTargets and Therapy 2017, 10:3285-3288

Published Date: 4 July 2017

Therapeutic value of 3-D printing template-assisted 125I-seed implantation in the treatment of malignant liver tumors

Han T, Yang X, Xu Y, Zheng Z, Yan Y, Wang N

OncoTargets and Therapy 2017, 10:3277-3283

Published Date: 3 July 2017

The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases

Pan DH, Wen DY, Luo YH, Chen G, Yang H, Chen JQ, He Y

OncoTargets and Therapy 2017, 10:3261-3276

Published Date: 3 July 2017

Hedgehog signaling pathway in colorectal cancer: function, mechanism, and therapy

Wu C, Zhu X, Liu W, Ruan T, Tao K

OncoTargets and Therapy 2017, 10:3249-3259

Published Date: 30 June 2017

LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism

Ding G, Peng Z, Shang J, Kang Y, Ning HB, Mao CS

OncoTargets and Therapy 2017, 10:3241-3247

Published Date: 30 June 2017

Targeted regulation of MiR-98 on E2F1 increases chemosensitivity of leukemia cells K562/A02

Huang YD, Hong XL, Hu J, Lu Q

OncoTargets and Therapy 2017, 10:3233-3239

Published Date: 29 June 2017

Exploration of the molecular mechanism of prostate cancer based on mRNA and miRNA expression profiles

Zhang X, Sun YY, Wang P, Yang CF, Li SW

OncoTargets and Therapy 2017, 10:3225-3232

Published Date: 29 June 2017

CXCL12 suppresses cisplatin-induced apoptosis through activation of JAK2/STAT3 signaling in human non-small-cell lung cancer cells

Wang M, Lin T, Wang YC, Gao S, Yang ZY, Hong X, Chen GY

OncoTargets and Therapy 2017, 10:3215-3224

Published Date: 29 June 2017

Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction

Shimada M, Fukuda M, Fukuda M, Kitazaki T, Hashiguchi K, Ikeda T, Yamaguchi H, Nakatomi K, Ashizawa K, Mukae H

OncoTargets and Therapy 2017, 10:3211-3214

Published Date: 29 June 2017

Association of estrogen receptor α PvuII and XbaI polymorphisms with prostate cancer susceptibility and risk stratification: a meta-analysis from case-control studies

Zhao YN, Zheng X, Zhang LJ, Hu Q, Guo YT, Jiang H, Shi SN, Zhang X

OncoTargets and Therapy 2017, 10:3203-3210

Published Date: 29 June 2017

The effect of circulating miR-223 on surveillance of different cancers: a meta-analysis

Zhang YF, Lin JB, Huang WJ, Cao Y, Liu Y, Wang TQ, Zhong WY, Wang DL, Mao RR, Chen XL

OncoTargets and Therapy 2017, 10:3193-3201

Published Date: 28 June 2017

Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report

Zhu Y, Liao X, Wang W, Xu C, Zhuang W, Zhong L, Du K, Chen Y, Chen G, Fang M

OncoTargets and Therapy 2017, 10:3187-3192

Published Date: 27 June 2017

Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors

Yao JC, Chan JA, Mita AC, Kundu MG, Hermosillo Reséndiz K, Hu K, Ravichandran S, Strosberg JR, Wolin EM

OncoTargets and Therapy 2017, 10:3177-3186

Published Date: 27 June 2017

Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients

Cymbaluk-Ploska A, Chudecka-Głaz A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Surowiec A, Menkiszak J

OncoTargets and Therapy 2017, 10:3169-3175

Published Date: 27 June 2017

Optimizing the treatment of bevacizumab as first-line therapy for human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer: an updated meta-analysis of published randomized trials

Li C, Xiang A, Chen X, Yin K, Lu J, Yin W

OncoTargets and Therapy 2017, 10:3155-3168

Published Date: 27 June 2017

Derived neutrophil to lymphocyte ratio and monocyte to lymphocyte ratio may be better biomarkers for predicting overall survival of patients with advanced gastric cancer

Song S, Li C, Li S, Gao H, Lan X, Xue Y

OncoTargets and Therapy 2017, 10:3145-3154

Published Date: 26 June 2017

Histone demethylase KDM2B upregulates histone methyltransferase EZH2 expression and contributes to the progression of ovarian cancer in vitro and in vivo

Kuang Y, Lu F, Guo J, Xu H, Wang Q, Xu C, Zeng L, Yi S

OncoTargets and Therapy 2017, 10:3131-3144

Published Date: 26 June 2017

The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis

Zhang X, Yin X, Shen P, Sun G, Yang Y, Liu J, Chen N, Zeng H

OncoTargets and Therapy 2017, 10:3123-3130

Published Date: 22 June 2017

Clinical efficacy evaluation of tyrosine kinase inhibitors for non-adenocarcinoma lung cancer patients harboring EGFR-sensitizing mutations

Song X, Wang Z

OncoTargets and Therapy 2017, 10:3119-3122

Published Date: 22 June 2017

Plasma fibrinogen and serum albumin levels (FA score) act as a promising prognostic indicator in non-small cell lung cancer

Chen P, Wang C, Cheng B, Nesa EU, Liu Y, Jia Y, Qu Y, Jiang Z, Han J, Cheng Y

OncoTargets and Therapy 2017, 10:3107-3118

Published Date: 21 June 2017

Comprehensive analysis of differential co-expression patterns reveal transcriptional dysregulation mechanism and identify novel prognostic lncRNAs in esophageal squamous cell carcinoma

Li Z, Yao Q, Zhao S, Wang Y, Li Y, Wang Z

OncoTargets and Therapy 2017, 10:3095-3105

Published Date: 21 June 2017

Association of FHIT expression and FHIT gene hypermethylation with liver cancer risk: a PRISMA-compliant meta-analysis

Zhang Y, Xu X, Chen Z, Zhao Z

OncoTargets and Therapy 2017, 10:3083-3093

Published Date: 20 June 2017

Original Research

Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapy

Bai Y, Wu HW, Ma X, Liu Y, Zhang YH

OncoTargets and Therapy 2017, 10:3071-3081

Published Date: 19 June 2017

The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis

Xu H, Ma Y, Deng F, Ju W, Sun X, Wang H

OncoTargets and Therapy 2017, 10:3059-3070

Published Date: 19 June 2017

Original Research

Isolated thoracic perfusion with chemofiltration for progressive malignant pleural mesothelioma

Aigner KR, Selak E, Gailhofer S

OncoTargets and Therapy 2017, 10:3049-3057

Published Date: 19 June 2017

Downregulation of lncRNA SDPR-AS is associated with poor prognosis in renal cell carcinoma

Ni W, Song E, Gong M, Li Y, Yao J, An R

OncoTargets and Therapy 2017, 10:3039-3047

Published Date: 19 June 2017

Rucaparib: the past, present, and future of a newly approved PARP inhibitor for ovarian cancer

Dockery LE, Gunderson CC, Moore KN

OncoTargets and Therapy 2017, 10:3029-3037

Published Date: 19 June 2017

Identification of key genes and molecular mechanisms associated with dedifferentiated liposarcoma based on bioinformatic methods

Yu H, Pei D, Chen L, Zhou X, Zhu H

OncoTargets and Therapy 2017, 10:3017-3027

Published Date: 16 June 2017

Skin toxicity evaluation in patients treated with cetuximab for metastatic colorectal cancer: a new tool for more accurate comprehension of quality of life impacts

De Tursi M, Zilli M, Carella C, Auriemma M, Lisco MN, Di Nicola M, Di Martino G, Natoli C, Amerio P

OncoTargets and Therapy 2017, 10:3007-3015

Published Date: 16 June 2017

Hepatic artery-infusion chemotherapy improved survival of hepatocellular carcinoma after radical hepatectomy

Feng M, Tang C, Feng W, Bao Y, Zheng Y, Shen J

OncoTargets and Therapy 2017, 10:3001-3005

Published Date: 14 June 2017

Combination of azacitidine and trichostatin A decreased the tumorigenic potential of lung cancer cells

Yang Y, Yin W, Wu FY, Fan J

OncoTargets and Therapy 2017, 10:2993-2999

Published Date: 14 June 2017

Overexpression of PD-L2 is associated with shorter relapse-free survival in patients with malignant salivary gland tumors

Chang H, Kim JS, Choi YJ, Cho J, Woo J, Kim A, Kim JS, Kang EJ

OncoTargets and Therapy 2017, 10:2983-2992

Published Date: 13 June 2017

Accelerated or hyperfractionated radiotherapy for esophageal carcinoma: a meta-analysis of randomized controlled trials

Liu YY, Kou CG, Su YY, Zhang YY, You YY, Zhang LL, Wang MH, Fu YL, Ren XJ, Yang YM

OncoTargets and Therapy 2017, 10:2971-2981

Published Date: 13 June 2017

Serum levels of IGF-1 and IGF-BP3 are associated with event-free survival in adult Ewing sarcoma patients treated with chemotherapy

de Groot S, Gelderblom H, Fiocco M, Bovée JVMG, van der Hoeven JJM, Pijl H, Kroep JR

OncoTargets and Therapy 2017, 10:2963-2970

Published Date: 13 June 2017

Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis

Yang B, Yan X, Liu L, Jiang C, Hou S

OncoTargets and Therapy 2017, 10:2951-2961

Published Date: 13 June 2017

Prognosis of prostate cancer with initial prostate-specific antigen >1,000 ng/mL at diagnosis

Kan HC, Hou CP, Lin YH, Tsui KH, Chang PL, Chen CL

OncoTargets and Therapy 2017, 10:2943-2949

Published Date: 12 June 2017

WWC3 downregulation correlates with poor prognosis and inhibition of Hippo signaling in human gastric cancer

Hou J, Zhou J

OncoTargets and Therapy 2017, 10:2931-2942

Published Date: 12 June 2017

Vasculogenic mimicry is associated with increased tumor-infiltrating neutrophil and poor outcome in esophageal squamous cell carcinoma

Zhang J, Zhang G, Hu P, Deng G, Liu Q, Qiao L, Luo H, Zhang J

OncoTargets and Therapy 2017, 10:2923-2930

Published Date: 9 June 2017

Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method

Chen X, Zhu X, Liang Z, Li L, Qu S, Chen K, Pan X

OncoTargets and Therapy 2017, 10:2909-2921

Published Date: 9 June 2017

Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment

Noronha V, Choughule A, Patil VM, Joshi A, Kumar R, Susan Joy Philip D, Banavali S, Dutt A, Prabhash K

OncoTargets and Therapy 2017, 10:2903-2908

Published Date: 9 June 2017

The prognostic value of cyclooxygenase-2 expression in patients with esophageal cancer: evidence from a meta-analysis

Hu Z, Yang Y, Zhao Y, Huang Y

OncoTargets and Therapy 2017, 10:2893-2901

Published Date: 9 June 2017

Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis

Li M, Yang X, Chen Y, Yang X, Dai X, Sun F, Zhang L, Zhan C, Feng M, Wang Q

OncoTargets and Therapy 2017, 10:2885-2892

Published Date: 7 June 2017

Upregulated long noncoding RNA PANDAR predicts an unfavorable prognosis and promotes tumorigenesis in cholangiocarcinoma

Xu Y, Jiang X, Cui Y

OncoTargets and Therapy 2017, 10:2873-2883

Published Date: 6 June 2017

PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy

Liu H, Zhang L, Zhang X, Cui Z

OncoTargets and Therapy 2017, 10:2865-2871

Published Date: 6 June 2017

Prognostic value of high IMP3 expression in solid tumors: a meta-analysis

Chen L, Xie Y, Li X, Gu L, Gao Y, Tang L, Chen J, Zhang X

OncoTargets and Therapy 2017, 10:2849-2863

Published Date: 6 June 2017

Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial–mesenchymal transition in esophageal squamous cell carcinoma

Bai X, Li Y, Zhang H, Wang F, He H, Yao J, Liu L, Li S

OncoTargets and Therapy 2017, 10:2837-2847

Published Date: 2 June 2017

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Retraction]

Yu L, Wang XL, Zhu D, Ding W, Wang L, Zhang C, Jiang X, Shen H, Liao S, Ma D, Hu Z, Wang H

OncoTargets and Therapy 2017, 10:2835-2836

Published Date: 2 June 2017

SUN1 silencing inhibits cell growth through G0/G1 phase arrest in lung adenocarcinoma

Huang W, Huang H, Wang L, Hu J, Song W

OncoTargets and Therapy 2017, 10:2825-2833

Published Date: 2 June 2017

Letter to the editor regarding the article “Prognostic role of long noncoding RNA NEAT1 in various carcinomas: a meta-analysis”

Yu H, Wang P, Zhang X

OncoTargets and Therapy 2017, 10:2823-2824

Published Date: 6 June 2017

MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2

Wu MH, Ye XX, Wang SC, Li QH, Lai YX, Yi YM

OncoTargets and Therapy 2017, 10:2815-2822

Published Date: 2 June 2017

Panel of seven long noncoding RNA as a candidate prognostic biomarker for ovarian cancer

Zhan XH, Dong C, Liu G, Li YX, Liu L

OncoTargets and Therapy 2017, 10:2805-2813

Published Date: 1 June 2017

Silencing of AQP3 induces apoptosis of gastric cancer cells via downregulation of glycerol intake and downstream inhibition of lipogenesis and autophagy

Chen L, Li Z, Zhang Q, Wei S, Li B, Zhang X, Zhang L, Li Q, Xu H, Xu Z

OncoTargets and Therapy 2017, 10:2791-2804

Published Date: 1 June 2017

The critical role of EGF-β-catenin signaling in the epithelial-mesenchymal transition in human glioblastoma

Wang X, Wang S, Li X, Jin S, Xiong F, Wang X

OncoTargets and Therapy 2017, 10:2781-2789

Published Date: 31 May 2017

Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corrigendum]

Ye T, Su J, Huang C, Yu D, Dai S, Huang X, Chen B, Zhou M

OncoTargets and Therapy 2017, 10:2779-2780

Published Date: 31 May 2017

The role of long noncoding RNA-LET in cell proliferation and invasion of nasopharyngeal carcinoma and its mechanism

Chen L, Sun L, Dong L, Cui P, Xia Z, Li C, Zhu Y

OncoTargets and Therapy 2017, 10:2769-2778

Published Date: 30 May 2017

Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study

Wu J, Li A, Yang J, Lu Y, Li J

OncoTargets and Therapy 2017, 10:2761-2768

Published Date: 29 May 2017

Pretreatment combination of platelet counts and neutrophil–lymphocyte ratio predicts survival of nasopharyngeal cancer patients receiving intensity-modulated radiotherapy

Lin YH, Chang KP, Lin YS, Chang TS

OncoTargets and Therapy 2017, 10:2751-2760

Published Date: 26 May 2017

Neoadjuvant chemotherapy combined with limb salvage surgery in patients with limb osteosarcoma of Enneking stage II: a retrospective study

Yuan G, Chen J, Wu D, Gao C

OncoTargets and Therapy 2017, 10:2745-2750

Published Date: 26 May 2017

Overexpression of ecotropic viral integration site-1 is a prognostic factor of lung squamous cell cancer

Xu X, Liu S, Ji X

OncoTargets and Therapy 2017, 10:2739-2744

Published Date: 26 May 2017

Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis [Corrigendum]

Xia S, Wang C, Postma EL, Yang Y, Ni X, Zhan W

OncoTargets and Therapy 2017, 10:2737-2738

Published Date: 29 May 2017

The prognostic value of nodal skip metastasis in resectable thoracic esophageal squamous cell carcinoma

Song G, Jing W, Xue S, Guo H, Yu J

OncoTargets and Therapy 2017, 10:2729-2736

Published Date: 25 May 2017

Leucine-rich glioma inactivated 3: integrative analyses support its prognostic role in glioma

Kwon NS, Kim DS, Yun HY

OncoTargets and Therapy 2017, 10:2721-2728

Published Date: 24 May 2017

miR-124 suppresses proliferation and invasion of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway by targeting Capn4

Hu H, Wang G, Li C

OncoTargets and Therapy 2017, 10:2711-2720

Published Date: 23 May 2017

MicroRNA-216a promotes the metastasis and epithelial–mesenchymal transition of ovarian cancer by suppressing the PTEN/AKT pathway

Liu H, Pan Y, Han X, Liu J, Li R

OncoTargets and Therapy 2017, 10:2701-2709

Published Date: 23 May 2017

Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials

Veettil SK, Teerawattanapong N, Ching SM, Lim KG, Saokaew S, Phisalprapa P, Chaiyakunapruk N

OncoTargets and Therapy 2017, 10:2689-2700

Published Date: 23 May 2017

Ezh2, a novel target in detection and therapy of breast cancer

Pourakbar S, Pluard TJ, Accurso AD, Farassati F

OncoTargets and Therapy 2017, 10:2685-2687

Published Date: 22 May 2017

Bisdemethoxycurcumin in combination with α-PD-L1 antibody boosts immune response against bladder cancer

Shao Y, Zhu W, Da J, Xu M, Wang Y, Zhou J, Wang Z

OncoTargets and Therapy 2017, 10:2675-2683

Published Date: 22 May 2017

Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer

Mearini E, Poli G, Cochetti G, Boni A, Egidi MG, Brancorsini S

OncoTargets and Therapy 2017, 10:2665-2673

Published Date: 22 May 2017

The prognostic value of neutrophil–lymphocyte ratio is superior to derived neutrophil–lymphocyte ratio in advanced gastric cancer treated with preoperative chemotherapy and sequential R0 resection: a 5-year follow-up

Jin H, Sun J, Zhu K, Liu X, Zhang Q, Shen Q, Gao Y, Yu J

OncoTargets and Therapy 2017, 10:2655-2664

Published Date: 22 May 2017

Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation

Pang X, Li Q, Ma Z, Shi Y, Ma Y, Li X, Cui W, Zhang W

OncoTargets and Therapy 2017, 10:2645-2654

Published Date: 19 May 2017

The novel long noncoding RNA RP11–357H14.17 acts as an oncogene by promoting cell proliferation and invasion in diffuse-type gastric cancer

Yang B, Luo TH, Zhang MJ, Lu ZM, Xue XC, Fang GN

OncoTargets and Therapy 2017, 10:2635-2643

Published Date: 18 May 2017

FOLFOX regimen plus dendritic cells–cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis

Liu Y, Zheng Z, Zhang QX, Zhou XL, Feng YK, Yan AQ

OncoTargets and Therapy 2017, 10:2621-2633

Published Date: 18 May 2017

RNA-binding protein HuR promotes bladder cancer progression by competitively binding to the long noncoding HOTAIR with miR-1

Yu DP, Zhang C, Gui JQ

OncoTargets and Therapy 2017, 10:2609-2619

Published Date: 17 May 2017

Holliday junction–recognizing protein promotes cell proliferation and correlates with unfavorable clinical outcome of hepatocellular carcinoma

Hu B, Wang Q, Wang Y, Chen J, Li P, Han M

OncoTargets and Therapy 2017, 10:2601-2607

Published Date: 17 May 2017

Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study

Sun Y, Wang Y, Han S, Xing B, Li H, Zhu Y, Zhou S, Wang X, Xu J, Tao R

OncoTargets and Therapy 2017, 10:2595-2600

Published Date: 17 May 2017

Original Research

The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia

Meier-Stephenson V, Riemer J, Narendran A

OncoTargets and Therapy 2017, 10:2581-2593

Published Date: 16 May 2017

Peripheral venous blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy

Chen L, Zuo YJ, Zhu LH, Zhang YX, Li S, Ma F, Han Y, Song HJ, Xue YW

OncoTargets and Therapy 2017, 10:2569-2580

Published Date: 17 May 2017

Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer

Du E, Wang L, Li C, Zhang C, Qu Y, Liu R, Xu Y, Yang K, Zhang Z

OncoTargets and Therapy 2017, 10:2561-2567

Published Date: 15 May 2017

Predictive significance of HMGCS2 for prognosis in resected Chinese esophageal squamous cell carcinoma patients

Tang H, Wu Y, Qin Y, Wang H, Jia Y, Yang S, Luo S, Wang Q

OncoTargets and Therapy 2017, 10:2553-2560

Published Date: 15 May 2017

Distinct implications of different BRCA mutations: efficacy of cytotoxic chemotherapy, PARP inhibition and clinical outcome in ovarian cancer

Hollis RL, Churchman M, Gourley C

OncoTargets and Therapy 2017, 10:2539-2551

Published Date: 11 May 2017

MicroRNA-381 enhances radiosensitivity in esophageal squamous cell carcinoma by targeting X-linked inhibitor of apoptosis protein

Zhou S, Cui Y, Yu D, Liang J, Zhang M, Ye W

OncoTargets and Therapy 2017, 10:2527-2538

Published Date: 11 May 2017

Review

New developments in the treatment of advanced squamous cell lung cancer: focus on afatinib

Hirsh V

OncoTargets and Therapy 2017, 10:2513-2526

Published Date: 11 May 2017

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives [Corrigendum]

McCulloch D, Brown C, Iland H

OncoTargets and Therapy 2017, 10:2511-2512

Published Date: 8 May 2017

Aberrant promoter methylation profiles and association with survival in patients with hepatocellular carcinoma

Zhong D, Cen H

OncoTargets and Therapy 2017, 10:2501-2509

Published Date: 8 May 2017

Clinicopathological significance of p14ARF expression in lung cancer: a meta-analysis

Wang F, Li H, Long J, Ye S

OncoTargets and Therapy 2017, 10:2491-2499

Published Date: 8 May 2017

Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment

Shi Y, Jia R, Fan X

OncoTargets and Therapy 2017, 10:2483-2489

Published Date: 8 May 2017

Original Research

Tyrosine kinase inhibitor combination therapy in first-line treatment of non-small-cell lung cancer: systematic review and network meta-analysis

Batson S, Mitchell SA, Windisch R, Damonte E, Munk VC, Reguart N

OncoTargets and Therapy 2017, 10:2473-2482

Published Date: 5 May 2017

Downregulation of long noncoding RNA TUG1 inhibits proliferation and induces apoptosis through the TUG1/miR-142/ZEB2 axis in bladder cancer cells

Liu Q, Liu H, Cheng HP, Li Y, Li XD, Zhu CY

OncoTargets and Therapy 2017, 10:2461-2471

Published Date: 5 May 2017

A retrospective study on the prognostic value of preoperative neutrophil/lymphocyte ratio in patients with primary small-cell carcinoma of the esophagus

Wang Y, Liu JF

OncoTargets and Therapy 2017, 10:2453-2459

Published Date: 5 May 2017

An isolated unusual digit metastasis from esophageal carcinoma: a case report

Chen Y, Tang W, Xiao H, Chen J, Zhao H, Shi J

OncoTargets and Therapy 2017, 10:2449-2452

Published Date: 9 May 2017

Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide

Haq S, Samuel V, Haxho F, Akasov R, Leko M, Burov SV, Markvicheva E, Szewczuk MR

OncoTargets and Therapy 2017, 10:2427-2447

Published Date: 4 May 2017

The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]

Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M

OncoTargets and Therapy 2017, 10:2425-2426

Published Date: 4 May 2017

Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response

Sun WW, Xu ZH, Lian P, Gao BL, Hu JA

OncoTargets and Therapy 2017, 10:2413-2424

Published Date: 4 May 2017

FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer [Retraction]

Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W

OncoTargets and Therapy 2017, 10:2411-2412

Published Date: 3 May 2017

The voice quality after laser surgery versus radiotherapy of T1a glottic carcinoma: systematic review and meta-analysis

Huang GJ, Luo MS, Zhang JX, Liu HB

OncoTargets and Therapy 2017, 10:2403-2410

Published Date: 3 May 2017

Immunogenicity of oncolytic vaccinia viruses JX-GFP and TG6002 in a human melanoma in vitro model: studying immunogenic cell death, dendritic cell maturation and interaction with cytotoxic T lymphocytes

Heinrich B, Klein J, Delic M, Goepfert K, Engel V, Geberzahn L, Lusky M, Erbs P, Preville X, Moehler M

OncoTargets and Therapy 2017, 10:2389-2401

Published Date: 2 May 2017

Curcumin exerts its antitumor activity through regulation of miR-7/Skp2/p21 in nasopharyngeal carcinoma cells

Feng S, Wang Y, Zhang R, Yang G, Liang Z, Wang Z, Zhang G

OncoTargets and Therapy 2017, 10:2377-2388

Published Date: 2 May 2017

Knockdown of a DIS3L2 promoter upstream long noncoding RNA (AC105461.1) enhances colorectal cancer stem cell properties in vitro by down-regulating DIS3L2

Liu W, Yu Q, Ma J, Cheng Y, Zhang H, Luo W, Yao J, Zhang H

OncoTargets and Therapy 2017, 10:2367-2376

Published Date: 2 May 2017

Lead identification for the K-Ras protein: virtual screening and combinatorial fragment-based approaches [Corrigendum]

Pathan AAK, Panthi B, Khan Z, Koppula PR, Alanazi M, Sachchidanand, Parine NR, Chourasia M

OncoTargets and Therapy 2017, 10:2365-2366

Published Date: 28 April 2017

Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies

Ilcus C, Bagacean C, Tempescul A, Popescu C, Parvu A, Cenariu M, Bocsan C, Zdrenghea M

OncoTargets and Therapy 2017, 10:2349-2363

Published Date: 28 April 2017

Epithelial-to-mesenchymal transition correlates with gefitinib resistance in NSCLC cells and the liver X receptor ligand GW3965 reverses gefitinib resistance through inhibition of vimentin

Hu Y, Zang J, Qin X, Yan D, Cao H, Zhou L, Ni J, Yu S, Wu J, Feng JF

OncoTargets and Therapy 2017, 10:2341-2348

Published Date: 28 April 2017

The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer

Bai H, Xiong L, Han B

OncoTargets and Therapy 2017, 10:2335-2340

Published Date: 27 April 2017

No genetic relationship between TLR2 rs4696480, rs3804100, and rs3804099 gene polymorphisms and female breast cancer in Saudi populations

Semlali A, Almutairi M, Parine NR, Al Amri A, Shaik JP, Al Naeem A, Abdulla Ajaj S, Rouabhia M, Alanazi MS

OncoTargets and Therapy 2017, 10:2325-2333

Published Date: 27 April 2017

B-cell-specific Moloney murine leukemia virus integration site 1: potential stratification factor and therapeutic target for epithelial ovarian cancer [Corrigendum]

Zhao Q, Gui T, Qian Q, Li L, Shen K

OncoTargets and Therapy 2017, 10:2323-2324

Published Date: 27 April 2017

Identification of potential biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma by bioinformatics analysis

Yang B, Chen Z, Huang Y, Han G, Li W

OncoTargets and Therapy 2017, 10:2315-2321

Published Date: 26 April 2017

Maintenance therapy with all-trans retinoic acid and arsenic trioxide improves relapse-free survival in adults with low- to intermediate-risk acute promyelocytic leukemia who have achieved complete remission after consolidation therapy

Liang B, Zheng ZY, Shi YF, Chen JJ, Hu XD, Qian HL, Shen ZJ, Jiang SF, Yu K, Feng JH

OncoTargets and Therapy 2017, 10:2305-2313

Published Date: 26 April 2017

Role of CT scan in differentiating the type of colorectal cancer

Li ZH, You DY, Gao DP, Yang GJ, Dong XX, Zhang DF, Ding YY

OncoTargets and Therapy 2017, 10:2297-2303

Published Date: 26 April 2017

Apatinib to combat EGFR-TKI resistance in an advanced non-small cell lung cancer patient with unknown EGFR status: a case report

Peng Y, Cui H, Liu Z, Liu D, Liu F, Song Y, Duan H, Qiu Y, Li Q

OncoTargets and Therapy 2017, 10:2289-2295

Published Date: 26 April 2017

Treatment-related severe and fatal adverse events with molecular targeted agents in the treatment of advanced gastric cancer: a meta-analysis

Wang L, Liu Y, Zhou W, Li W

OncoTargets and Therapy 2017, 10:2281-2287

Published Date: 26 April 2017

Original Research

Meta-analysis of the impact of de novo and acquired EGFR T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIs

Liu Y, Sun L, Xiong Z, Sun X, Zhang S, Ma J, Han C

OncoTargets and Therapy 2017, 10:2267-2279

Published Date: 24 April 2017

Original Research

Results of adjuvant radiation therapy for locoregional perihilar cholangiocarcinoma after curative intent resection

Leng KM, Liu YP, Wang ZD, Zhong XY, Liao GQ, Kang PC, Cui YF, Jiang XM

OncoTargets and Therapy 2017, 10:2257-2266

Published Date: 21 April 2017

Relationship between computed tomography morphology and prognosis of patients with stage I non-small cell lung cancer

Ma J, Yang Y, Wang Y, Zhang X, Gu X, Wang Z

OncoTargets and Therapy 2017, 10:2249-2256

Published Date: 21 April 2017

PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro

Cui W, Zheng S, Liu Z, Wang W, Cai Y, Bi R, Cao B, Zhou X

OncoTargets and Therapy 2017, 10:2239-2247

Published Date: 20 April 2017

Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer

Zhang J, Liu Q, Qiao L, Hu P, Deng G, Liang N, Xie J, Luo H, Zhang J

OncoTargets and Therapy 2017, 10:2227-2237

Published Date: 20 April 2017

NVP-AUY922, a novel HSP90 inhibitor, inhibits the progression of malignant pheochromocytoma in vitro and in vivo

Lian JP, Lin D, Xie X, Xu Y, Xu L, Meng L, Zhu Y

OncoTargets and Therapy 2017, 10:2219-2226

Published Date: 19 April 2017

Radiobiological evaluation of simultaneously dose-escalated versus non-escalated intensity-modulated radiation therapy for patients with upper thoracic esophageal cancer

Huang BT, Wu LL, Guo LJ, Xu LY, Huang RH, Lin PX, Chen JZ, Li DR, Chen CZ

OncoTargets and Therapy 2017, 10:2209-2217

Published Date: 19 April 2017

Impact of platelet to lymphocyte ratio and metabolic syndrome on the prognosis of colorectal cancer patients

You J, Zhang H, Shen Y, Chen C, Liu W, Zheng M, Van Poucke S, Guo G, Huang Z

OncoTargets and Therapy 2017, 10:2199-2208

Published Date: 18 April 2017

Allergic conditions are not associated with the risk of non-Hodgkin’s lymphoma or Hodgkin’s lymphoma: a systematic review and meta-analysis

Yang J, Xu H, Liang X, Lv S, Lin B, Jia Y

OncoTargets and Therapy 2017, 10:2189-2198

Published Date: 18 April 2017

Novel insights into circular RNAs in clinical application of carcinomas

Rong D, Tang W, Li Z, Zhou J, Shi J, Wang H, Cao H

OncoTargets and Therapy 2017, 10:2183-2188

Published Date: 18 April 2017

Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients

Luo D, Chen W, Tian Y, Li J, Xu X, Chen C, Li F

OncoTargets and Therapy 2017, 10:2173-2181

Published Date: 18 April 2017

Monosomal karyotype in myeloid neoplasias: a literature review

Anelli L, Pasciolla C, Zagaria A, Specchia G, Albano F

OncoTargets and Therapy 2017, 10:2163-2171

Published Date: 20 April 2017

Prognostic value of pretreatment albumin–globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection

Liu J, Chen S, Geng Q, Liu X, Kong P, Zhan Y, Xu D

OncoTargets and Therapy 2017, 10:2155-2162

Published Date: 13 April 2017

Soluble cytotoxic T-lymphocyte antigen 4: a favorable predictor in malignant tumors after therapy

Liu Q, Hu P, Deng G, Zhang J, Liang N, Xie J, Qiao L, Luo H, Zhang J

OncoTargets and Therapy 2017, 10:2147-2154

Published Date: 12 April 2017

Inhibition of PCSK9 protects against radiation-induced damage of prostate cancer cells

Gan S, Ye J, Wang L, Qu F, Chu C, Tian Y, Yang W, Cui X

OncoTargets and Therapy 2017, 10:2139-2146

Published Date: 12 April 2017

miR-762 can negatively regulate menin in ovarian cancer

Hou R, Yang Z, Wang S, Chu D, Liu Q, Liu J, Jiang L

OncoTargets and Therapy 2017, 10:2127-2137

Published Date: 12 April 2017

A blockade of PD-L1 produced antitumor and antimetastatic effects in an orthotopic mouse pancreatic cancer model via the PI3K/AkT/MTOR signaling pathway

Zhao L, Li C, Liu F, Zhao Y, Liu J, Hua Y, Liu J, Huang J, Ge C

OncoTargets and Therapy 2017, 10:2115-2126

Published Date: 12 April 2017

Gastric cancer, nutritional status, and outcome

Liu X, Qiu H, Kong P, Zhou Z, Sun X

OncoTargets and Therapy 2017, 10:2107-2114

Published Date: 12 April 2017

Targeting the PD-1 pathway in pediatric solid tumors and brain tumors

Wagner LM, Adams VR

OncoTargets and Therapy 2017, 10:2097-2106

Published Date: 12 April 2017

Can involved-field irradiation replace elective nodal irradiation in chemoradiotherapy for esophageal cancer? A systematic review and meta-analysis

Wang X, Miao C, Chen Z, Li W, Yuan S, Yu J, Hu X

OncoTargets and Therapy 2017, 10:2087-2095

Published Date: 11 April 2017

Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors

Rossmeisl JH, Hall-Manning K, Robertson JL, King JN, Davalos RV, Debinski W, Elankumaran S

OncoTargets and Therapy 2017, 10:2077-2085

Published Date: 12 April 2017

Therapeutic outcome of nasopharyngeal carcinoma with cranial nerve palsy: a single institution experience of 104 patients

Huang CC, Fang FM, Chen HC, Hsu HC, Huang TL, Su YL, Chang YC

OncoTargets and Therapy 2017, 10:2069-2075

Published Date: 10 April 2017

The role of KPNβ1 in neuro-oncology

Lilley M, Farassati F

OncoTargets and Therapy 2017, 10:2067-2068

Published Date: 10 April 2017

Spotlight on bevacizumab and its potential in the treatment of malignant pleural mesothelioma: the evidence to date

Levin PA, Dowell JE

OncoTargets and Therapy 2017, 10:2057-2066

Published Date: 7 April 2017

Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7

Tang W, Ji M, He G, Yang L, Niu Z, Jian M, Wei Y, Ren L, Xu J

OncoTargets and Therapy 2017, 10:2045-2056

Published Date: 7 April 2017

Patient considerations in metastatic colorectal cancer – role of panitumumab

Rogers JE

OncoTargets and Therapy 2017, 10:2033-2044

Published Date: 7 April 2017

Expression and significance of GRHL2 in esophageal cancer

Shao CC, Ji CS, Wang XQ, Hu B

OncoTargets and Therapy 2017, 10:2025-2031

Published Date: 7 April 2017

REG3A promotes the proliferation, migration, and invasion of gastric cancer cells

Chen ZF, Huang ZM, Xue HB, Lin XQ, Chen RP, Chen MJ, Jin RF

OncoTargets and Therapy 2017, 10:2017-2023

Published Date: 6 April 2017

Role of postmastectomy radiotherapy in early-stage (T1–2N0–1M0) triple-negative breast cancer: a systematic review

Chen F, Pu F

OncoTargets and Therapy 2017, 10:2009-2016

Published Date: 6 April 2017

Altered status of programmed death-ligand 1 after recurrence in resected lung adenocarcinoma patients

Chen J, Li H, Pang RL, Huang J

OncoTargets and Therapy 2017, 10:2003-2007

Published Date: 6 April 2017

Long noncoding RNA NBAT-1 suppresses tumorigenesis and predicts favorable prognosis in ovarian cancer

Yan CS, Jiang Y, Wan YC, Zhang L, Liu JH, Zhou SL, Cheng WJ

OncoTargets and Therapy 2017, 10:1993-2002

Published Date: 6 April 2017

Review

The activity, safety, and evolving role of brigatinib in patients with ALK-rearranged non-small cell lung cancers

Sabari JK, Santini FC, Schram AM, Bergagnini I, Chen R, Mrad C, Lai WV, Arbour KC, Drilon A

OncoTargets and Therapy 2017, 10:1983-1992

Published Date: 6 April 2017

Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation

Andersen MN, Ludvigsen M, Abildgaard N, Petruskevicius I, Hjortebjerg R, Bjerre M, Honoré B, Møller HJ, Andersen NF

OncoTargets and Therapy 2017, 10:1977-1982

Published Date: 4 April 2017

HSD17B12 gene rs11037575 C>T polymorphism confers neuroblastoma susceptibility in a Southern Chinese population

Zhang ZR, Zou Y, Zhu JH, Zhang RZ, Yang TY, Wang FH, Xia HM, He J, Feng ZC

OncoTargets and Therapy 2017, 10:1969-1975

Published Date: 4 April 2017

Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors

Sun S, Yu H, Wang H, Zhao X, Zhao X, Wu X, Qiao J, Chang J, Wang J

OncoTargets and Therapy 2017, 10:1955-1967

Published Date: 3 April 2017

Clinical significance of serum cathepsin B and cystatin C levels and their ratio in the prognosis of patients with esophageal cancer

Yan Y, Zhou K, Wang L, Wang F, Chen X, Fan Q

OncoTargets and Therapy 2017, 10:1947-1954

Published Date: 3 April 2017

Apoptotic and genomic effects of corilagin on SKOV3 ovarian cancer cell line

Attar R, Cincin ZB, Bireller ES, Cakmakoglu B

OncoTargets and Therapy 2017, 10:1941-1946

Published Date: 31 March 2017

FAM172A expression in circulating tumor cells for prediction of high-risk subgroups of colorectal cancer

Xu C, Zhang C, Wang H, Yang H, Li G, Fei Z, Li W

OncoTargets and Therapy 2017, 10:1933-1939

Published Date: 30 March 2017

Non-small-cell lung cancer cell lines A549 and NCI-H460 express hypoxanthine guanine phosphoribosyltransferase on the plasma membrane

Townsend MH, Anderson MD, Weagel EG, Velazquez EJ, Weber KS, Robison RA, O'Neill KL

OncoTargets and Therapy 2017, 10:1921-1932

Published Date: 30 March 2017

Expression of SHP-1 and SOCS6 in patients with acute leukemia and their clinical implication

Liu J, Zheng Y, Gao J, Zhu G, Gao K, Zhang W, Shi F, Shi Q

OncoTargets and Therapy 2017, 10:1915-1920

Published Date: 29 March 2017

Spotlight on ibrutinib and its potential in frontline treatment of chronic lymphocytic leukemia

Khan M, Gibbons JL, Ferrajoli A

OncoTargets and Therapy 2017, 10:1909-1914

Published Date: 29 March 2017

Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis

Liu Y, Mu Y, Zhang A, Ren SD, Wang WH, Xie JP, Zhang YX, Zhou CH

OncoTargets and Therapy 2017, 10:1897-1908

Published Date: 29 March 2017

Clinical course and outcome of patients with high-level microsatellite instability cancers in a real-life setting: a retrospective analysis

Halpern N, Goldberg Y, Kadouri L, Duvdevani M, Hamburger T, Peretz T, Hubert A

OncoTargets and Therapy 2017, 10:1889-1896

Published Date: 29 March 2017

Genetic variants and increased risk of meningioma: an updated meta-analysis

Han X, Wang W, Wang L, Wang X, Li G

OncoTargets and Therapy 2017, 10:1875-1888

Published Date: 28 March 2017

DNMT1 regulates human endometrial carcinoma cell proliferation

Wang X, Li B

OncoTargets and Therapy 2017, 10:1865-1873

Published Date: 29 March 2017

EGFR mutation in squamous cell carcinoma of the lung: does it carry the same connotation as in adenocarcinomas?

Joshi A, Zanwar S, Noronha V, Patil VM, Chougule A, Kumar R, Janu A, Mahajan A, Kapoor A, Prabhash K

OncoTargets and Therapy 2017, 10:1859-1863

Published Date: 28 March 2017

Pancreatic solitary fibrous tumor in a toddler managed by pancreaticoduodenectomy: a case report and review of the literature

Sheng Q, Xu W, Liu J, Shen B, Deng X, Wu Y, Wu W, Yu S, Wang X, Lv Z

OncoTargets and Therapy 2017, 10:1853-1858

Published Date: 27 March 2017

Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis

Wu J, Cheng G, Zhang C, Zheng Y, Xu H, Yang H, Hua L

OncoTargets and Therapy 2017, 10:1843-1852

Published Date: 27 March 2017

Predictive parameters in hypofractionated whole-breast 3D conformal radiotherapy according to the Ontario Canadian trial

Lazzari G, Terlizzi A, Della Vittoria Scarpati G, Perri F, De Chiara V, Turi B, Silvano G

OncoTargets and Therapy 2017, 10:1835-1842

Published Date: 24 March 2017

Anti-RhoC siRNAs inhibit the proliferation and invasiveness of breast cancer cells via modulating the KAI1, MMP9, and CXCR4 expression

Xu X, Shen H, Zhu L, Lu J, Zhang L, Luo Z, Wu Y

OncoTargets and Therapy 2017, 10:1827-1834

Published Date: 23 March 2017

Salvage treatment with apatinib for advanced non-small-cell lung cancer

Song Z, Yu X, Lou G, Shi X, Zhang Y

OncoTargets and Therapy 2017, 10:1821-1825

Published Date: 23 March 2017

Role of Nrf2 signaling pathway in the radiation tolerance of patients with head and neck squamous cell carcinoma: an in vivo and in vitro study

Wang T, Hu P, Li B, Zhang J, Cheng Y, Liang Y

OncoTargets and Therapy 2017, 10:1809-1819

Published Date: 23 March 2017

Understanding the role of PD-L1/PD1 pathway blockade and autophagy in cancer therapy

Robainas M, Otano R, Bueno S, Ait-Oudhia S

OncoTargets and Therapy 2017, 10:1803-1807

Published Date: 23 March 2017

Associations of NQO1 C609T and NQO1 C465T polymorphisms with acute leukemia risk: a PRISMA-compliant meta-analysis

He H, Zhai X, Liu X, Zheng J, Zhai Y, Gao F, Chen Y, Lu J

OncoTargets and Therapy 2017, 10:1793-1801

Published Date: 23 March 2017

Focal adhesion kinases crucially regulate TGFβ-induced migration and invasion of bladder cancer cells via Src kinase and E-cadherin

Kong D, Chen F, Sima N

OncoTargets and Therapy 2017, 10:1783-1792

Published Date: 23 March 2017

Prognostic value of FOXQ1 in patients with malignant solid tumors: a meta-analysis

Cui X, Zhang J, Lv J, Yan Y, Liu X, Wang J, Lv Y, Zhang J

OncoTargets and Therapy 2017, 10:1777-1781

Published Date: 23 March 2017

Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer

Shi L, Zheng H, Hu W, Zhou B, Dai X, Zhang Y, Liu Z, Wu X, Zhao C, Liang G

OncoTargets and Therapy 2017, 10:1767-1776

Published Date: 23 March 2017

Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291)

Saad N, Poudel A, Basnet A, Gajra A

OncoTargets and Therapy 2017, 10:1757-1766

Published Date: 22 March 2017

Fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis

Xia S, Wang C, Postma EL, Yang Y, Ni X, Zhan W

OncoTargets and Therapy 2017, 10:1743-1755

Published Date: 22 March 2017

The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer

Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M

OncoTargets and Therapy 2017, 10:1735-1742

Published Date: 21 March 2017

The associations between five polymorphisms of vascular endothelial growth factor and renal cell carcinoma risk: an updated meta-analysis

Wang J, Shen CX, Fu Y, Yu T, Song J

OncoTargets and Therapy 2017, 10:1725-1734

Published Date: 21 March 2017

Diagnostic and prognostic roles of IRAK1 in hepatocellular carcinoma tissues: an analysis of immunohistochemistry and RNA-sequencing data from the cancer genome atlas

Ye ZH, Gao L, Wen DY, He Y, Pang YY, Chen G

OncoTargets and Therapy 2017, 10:1711-1723

Published Date: 21 March 2017

Efficacy and safety of icotinib in patients with brain metastases from lung adenocarcinoma [Corrigendum]

Xu J, Liu X, Yang S, Zhang X, Shi Y

OncoTargets and Therapy 2017, 10:1709-1710

Published Date: 21 March 2017

Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature [Corrigendum]

Yang X, Cao YD, Chen C, Liu L, Wang C, Liu SC

OncoTargets and Therapy 2017, 10:1707-1708

Published Date: 21 March 2017

Suppression of microRNA-629 enhances sensitivity of cervical cancer cells to 1′S-1′-acetoxychavicol acetate via regulating RSU1

Phuah NH, Azmi MN, Awang K, Nagoor NH

OncoTargets and Therapy 2017, 10:1695-1705

Published Date: 20 March 2017

Primary pancreatic lymphoma: two case reports and a literature review

Yu L, Chen Y, Xing L

OncoTargets and Therapy 2017, 10:1687-1694

Published Date: 20 March 2017

Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma

Ning X, Deng Y

OncoTargets and Therapy 2017, 10:1673-1686

Published Date: 20 March 2017

Role of cytokines and chemokines in alcohol-induced tumor promotion

Chen D, Zhang F, Ren H, Luo J, Wang S

OncoTargets and Therapy 2017, 10:1665-1671

Published Date: 17 March 2017

Human omental adipose-derived mesenchymal stem cell-conditioned medium alters the proteomic profile of epithelial ovarian cancer cell lines in vitro

Zhang YL, Dong WH, Wang JJ, Cai J, Wang ZH

OncoTargets and Therapy 2017, 10:1655-1663

Published Date: 17 March 2017

Sonidegib: mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas

Jain S, Song R, Xie J

OncoTargets and Therapy 2017, 10:1645-1653

Published Date: 16 March 2017

Evaluation of efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma using magnetic resonance diffusion-weighted imaging

Wu X, Wang J, Ji J, Chen M, Song J

OncoTargets and Therapy 2017, 10:1637-1643

Published Date: 16 March 2017

MicroRNA-145 inhibits the activation of the mTOR signaling pathway to suppress the proliferation and invasion of invasive pituitary adenoma cells by targeting AKT3 in vivo and in vitro

Zhou K, Fan Y, Wu P, Duysenbi S, Feng Z, Du G, Zhang T

OncoTargets and Therapy 2017, 10:1625-1635

Published Date: 16 March 2017

CDKL1 promotes tumor proliferation and invasion in colorectal cancer

Qin C, Ren L, Ji M, Lv S, Wei Y, Zhu D, Lin Q, Xu P, Chang W, Xu J

OncoTargets and Therapy 2017, 10:1613-1624

Published Date: 16 March 2017

TCF21 functions as a tumor suppressor in colorectal cancer through inactivation of PI3K/AKT signaling

Dai Y, Duan H, Duan C, Zhu H, Zhou R, Pei H, Shen L

OncoTargets and Therapy 2017, 10:1603-1611

Published Date: 14 March 2017

Review

Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives

McCulloch D, Brown C, Iland H

OncoTargets and Therapy 2017, 10:1585-1601

Published Date: 14 March 2017

SDF1-3'A polymorphism is associated with increased risk of hematological malignancy: a meta-analysis

Zhang X, Fan Y, Li Z

OncoTargets and Therapy 2017, 10:1575-1583

Published Date: 14 March 2017

Mechanism of immune evasion in breast cancer

Wang M, Zhang C, Song Y, Wang Z, Wang Y, Luo F, Xu Y, Zhao Y, Wu Z, Xu Y

OncoTargets and Therapy 2017, 10:1561-1573

Published Date: 14 March 2017

Knockdown of IQGAP1 inhibits proliferation and epithelial–mesenchymal transition by Wnt/β-catenin pathway in thyroid cancer

Su D, Liu Y, Song T

OncoTargets and Therapy 2017, 10:1549-1559

Published Date: 13 March 2017

Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study

Yang J, Li S, Lv M, Wu Y, Chen Z, Shen Y, Wang B, Chen L, Yi M, Yang J

OncoTargets and Therapy 2017, 10:1535-1548

Published Date: 13 March 2017

Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma

Vatte C, Al Amri AM, Cyrus C, Chathoth S, Acharya S, Hashim TM, Al Ali Z, Alshreadah ST, Alsayyah A, Al-Ali AK

OncoTargets and Therapy 2017, 10:1527-1533

Published Date: 13 March 2017

Apatinib treatment combined with chemotherapy for advanced epithelial ovarian cancer: a case report

Deng L, Wang Y, Lu W, Liu Q, Wu J, Jin J

OncoTargets and Therapy 2017, 10:1521-1525

Published Date: 13 March 2017

MTA1 promotes proliferation and invasion in human gastric cancer cells [Retraction]

Yao Y, Feng S, Xiao M, Li Y, Yang L, Gong J

OncoTargets and Therapy 2017, 10:1519-1520

Published Date: 10 March 2017

Adverse prognostic impact of TGFB1 T869C polymorphism in non-small-cell lung cancer

Sang Y, Bi X, Liu Y, Zhang W, Wang D

OncoTargets and Therapy 2017, 10:1513-1518

Published Date: 10 March 2017

Silencing Trim59 inhibits invasion/migration and epithelial-to-mesenchymal transition via TGF-β/Smad2/3 signaling pathway in bladder cancer cells

Chen W, Zhao K, Miao C, Xu A, Zhang J, Zhu J, Su S, Wang Z

OncoTargets and Therapy 2017, 10:1503-1512

Published Date: 9 March 2017

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer

Aydin AM, Woldu SL, Hutchinson RC, Boegemann M, Bagrodia A, Lotan Y, Margulis V, Krabbe LM

OncoTargets and Therapy 2017, 10:1487-1502

Published Date: 9 March 2017

Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors

Guo W, Zheng YB, Xu B, Ma F, Li C, Zhang XQ, Wang Y, Chang XT

OncoTargets and Therapy 2017, 10:1475-1485

Published Date: 8 March 2017

Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors

Guo C, Chen X, Xiao W, Wang Q, Sun K, Wang Z

OncoTargets and Therapy 2017, 10:1465-1474

Published Date: 7 March 2017

Chronological changes in lung cancer surgery in a single Japanese institution

Nakamura H, Sakai H, Kimura H, Miyazawa T, Marushima H, Saji H

OncoTargets and Therapy 2017, 10:1459-1464

Published Date: 6 March 2017

Arm lymphoscintigraphy after axillary lymph node dissection or sentinel lymph node biopsy in breast cancer

Sarri AJ, Dias R, Laurienzo CE, Gonçalves MCP, Dias DS, Moriguchi SM

OncoTargets and Therapy 2017, 10:1451-1457

Published Date: 6 March 2017

Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma

Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z

OncoTargets and Therapy 2017, 10:1441-1449

Published Date: 6 March 2017

GSTM1 polymorphism is related to risks of nasopharyngeal cancer and laryngeal cancer: a meta-analysis

Zhang F, Wu X, Niu J, Kang X, Cheng L, Lv Y, Wu M

OncoTargets and Therapy 2017, 10:1433-1440

Published Date: 6 March 2017

MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK

Chen P, Xu W, Luo Y, Zhang Y, He Y, Yang S, Yuan Z

OncoTargets and Therapy 2017, 10:1423-1431

Published Date: 6 March 2017

Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia

Koprivnikar J, McCloskey J, Faderl S

OncoTargets and Therapy 2017, 10:1413-1422

Published Date: 6 March 2017

Nonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?

Ali MA, Lacin S, Abdel-Wahab R, Uemura M, Hassan M, Rashid A, Duda DG, Kaseb AO

OncoTargets and Therapy 2017, 10:1403-1412

Published Date: 3 March 2017

HMGB1 is negatively correlated with the development of endometrial carcinoma and prevents cancer cell invasion and metastasis by inhibiting the process of epithelial-to-mesenchymal transition

Luan XR, Ma CJ, Wang P, Lou FL

OncoTargets and Therapy 2017, 10:1389-1402

Published Date: 3 March 2017

Arterial stiffness in hematologic malignancies

Mozos I, Borzak G, Caraba A, Mihaescu R

OncoTargets and Therapy 2017, 10:1381-1388

Published Date: 3 March 2017

Case Series

The world of targeted therapies in kidney cancers: pitfalls, tips and tricks

Vallard A, Trone JC, Langrand-Escure J, Espenel S, Guy JB, Rancoule C, Xia YX, El Meddeb Hamrouni A, Ben Mrad M, Magné N

OncoTargets and Therapy 2017, 10:1375-1380

Published Date: 3 March 2017

Original Research

Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma

Qiao Y, Li J, Shi C, Wang W, Qu X, Xiong M, Sun Y, Li D, Zhao X, Zhang D

OncoTargets and Therapy 2017, 10:1363-1373

Published Date: 3 March 2017

MicroRNA-148a suppresses proliferation and invasion potential of non-small cell lung carcinomas via regulation of STAT3

He M, Xue Y

OncoTargets and Therapy 2017, 10:1353-1361

Published Date: 2 March 2017

125I brachytherapy of locally advanced non-small-cell lung cancer after one cycle of first-line chemotherapy：a comparison with best supportive care

Song J, Fan X, Zhao Z, Chen M, Chen W, Wu F, Zhang D, Chen L, Tu J, Ji J

OncoTargets and Therapy 2017, 10:1345-1352

Published Date: 2 March 2017

Evidence from a meta-analysis: is nivolumab neurotoxic in cancer patients?

Kong X, Kong Y

OncoTargets and Therapy 2017, 10:1335-1344

Published Date: 1 March 2017

Clarifying the molecular mechanism associated with carfilzomib resistance in human multiple myeloma using microarray gene expression profile and genetic interaction network

Zheng Z, Liu T, Zheng J, Hu J

OncoTargets and Therapy 2017, 10:1327-1334

Published Date: 1 March 2017

Salinomycin repressed the epithelial–mesenchymal transition of epithelial ovarian cancer cells via downregulating Wnt/β-catenin pathway

Li R, Dong T, Hu C, Lu J, Dai J, Liu P

OncoTargets and Therapy 2017, 10:1317-1325

Published Date: 28 February 2017

Downregulation of long noncoding RNA HOTAIRM1 promotes monocyte/dendritic cell differentiation through competitively binding to endogenous miR-3960

Xin J, Li J, Feng Y, Wang L, Zhang Y, Yang R

OncoTargets and Therapy 2017, 10:1307-1315

Published Date: 1 March 2017

Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) – non-interventional study

Losem C, Koenigsmann M, Rudolph C

OncoTargets and Therapy 2017, 10:1295-1305

Published Date: 28 February 2017

Discrimination of serous cystadenoma from mucinous cystadenoma in the pancreas with contrast-enhanced ultrasonography: a prospective study in 61 patients

Sun Y, Zhou F, Liu F, Hu Y, Tan S, Liang P, Linghu EQ, Yu X

OncoTargets and Therapy 2017, 10:1285-1294

Published Date: 28 February 2017

Sequential treatment of tyrosine kinase inhibitor and platinum-based doublet chemotherapy on EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled clinical trials

Qiao L, Wang J, Long G, Jiang Y

OncoTargets and Therapy 2017, 10:1279-1284

Published Date: 28 February 2017

MicroRNA-194 modulates epithelial–mesenchymal transition in human colorectal cancer metastasis

Cai H, Chen X, Tang Y, Deng Y

OncoTargets and Therapy 2017, 10:1269-1278

Published Date: 28 February 2017

Arenobufagin activates p53 to trigger esophageal squamous cell carcinoma cell apoptosis in vitro and in vivo

Lv J, Lin S, Peng P, Cai C, Deng J, Wang M, Li X, Lin R, Lin Y, Fang A, Li Q